Brian Greenwood

Q: What Schools Are Affiliated With Brian Greenwood

Brian Greenwood is affiliated with the following schools: University of Oxford, University of Edinburgh, Baylor College of Medicine, London School of Hygiene and Tropical Medicine, Ahmadu Bello University

Brian Greenwood's AcademicInfluence.com Rankings

Brian Greenwood

Philosophy

#2134

World Rank

#3708

Historical Rank

Logic

#454

World Rank

#853

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Why Is Brian Greenwood Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Sir Brian Mellor Greenwood, CBE, FRCP, FRS is a British physician, biomedical research scientist, academic, and recipient of the first Hideyo Noguchi Africa Prize. Greenwood is the Manson Professor of Clinical Tropical Medicine, London School of Hygiene and Tropical Medicine.

(See a Problem?)

Brian Greenwood's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Common West African HLA antigens are associated with protection from severe malaria (1991) (1577)
Variation in the TNF-α promoter region associated with susceptibility to cerebral malaria (1994) (1131)
Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial (2005) (938)
Epidemic meningitis, meningococcaemia, and Neisseria meningitidis (2007) (899)
TNF concentration in fatal cerebral, non-fatal cerebral, and uncomplicated Plasmodium falciparum malaria (1990) (884)
Malaria: progress, perils, and prospects for eradication. (2008) (730)
Overdiagnosis of malaria in patients with severe febrile illness in Tanzania: a prospective study (2004) (711)
A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants. (2012) (689)
Malaria in 2002 (2002) (680)
Molecular analysis of the association of HLA-B53 and resistance to severe malaria (1992) (665)
A Research Agenda to Underpin Malaria Eradication (2011) (659)
Mortality and morbidity from malaria among children in a rural area of The Gambia, West Africa. (1987) (658)
Natural selection of hemi- and heterozygotes for G6PD deficiency in Africa by resistance to severe malaria (1995) (566)
The contribution of vaccination to global health: past, present and future (2014) (566)
Efficacy of RTS,S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trial (2001) (556)
First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children. (2011) (531)
A polymorphism that affects OCT-1 binding to the TNF promoter region is associated with severe malaria (1999) (520)
Changes in the burden of malaria in sub-Saharan Africa. (2010) (515)
Human cerebral malaria: association with erythrocyte rosetting and lack of anti-rosetting antibodies (1990) (481)
Mortality and morbidity from malaria in Gambian children after introduction of an impregnated bednet programme (1995) (469)
Antibodies to blood stage antigens of Plasmodium falciparum in rural Gambians and their relation to protection against infection. (1989) (466)
Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria. (1994) (459)
The effect of insecticide-treated bed nets on mortality of Gambian children (1991) (456)
Changes in malaria indices between 1999 and 2007 in The Gambia: a retrospective analysis (2008) (447)
Association between an MHC class II allele and clearance of hepatitis B virus in the Gambia. (1995) (437)
Shrinking the malaria map: progress and prospects (2010) (419)
Randomised trial of Haemophilus influenzae type-b tetanus protein conjugate for prevention of pneumonia and meningitis in Gambian infants (1997) (412)
Efficacy and Safety of the RTS,S/AS01 Malaria Vaccine during 18 Months after Vaccination: A Phase 3 Randomized, Controlled Trial in Children and Young Infants at 11 African Sites (2014) (393)
Respiratory syncytial virus infection in tropical and developing countries (1998) (367)
Why do some African children develop severe malaria? (1991) (352)
Carriage of pneumococci after pneumococcal vaccination (1996) (352)
Clinical immunity to Plasmodium falciparum malaria is associated with serum antibodies to the 19-kDa C-terminal fragment of the merozoite surface antigen, PfMSP-1. (1996) (334)
Manson Lecture. Meningococcal meningitis in Africa. (1999) (322)
Association of transmission intensity and age with clinical manifestations and case fatality of severe Plasmodium falciparum malaria. (2005) (318)
Heterozygote advantage for HLA class-II type in hepatitis B virus infection (1997) (309)
The changing and dynamic epidemiology of meningococcal disease. (2012) (308)
Elimination of Haemophilus influenzae type b (Hib) disease from The Gambia after the introduction of routine immunisation with a Hib conjugate vaccine: a prospective study (2005) (299)
From malaria control to eradication: The WHO perspective (2009) (290)
Genetic Diversity and Protective Efficacy of the RTS,S/AS01 Malaria Vaccine. (2015) (287)
Association of malaria parasite population structure, HLA, and immunological antagonism. (1998) (281)
Amodiaquine alone, amodiaquine+sulfadoxine-pyrimethamine, amodiaquine+artesunate, and artemether-lumefantrine for outpatient treatment of malaria in Tanzanian children: a four-arm randomised effectiveness trial (2005) (281)
Immunosuppression in children with malaria. (1972) (277)
Identification of hot spots of malaria transmission for targeted malaria control. (2010) (277)
Naturally acquired cellular and humoral immune responses to the major merozoite surface antigen (Pf MSP1) of Plasmodium falciparum are associated with reduced malaria morbidity (1992) (274)
Age-Patterns of Malaria Vary with Severity, Transmission Intensity and Seasonality in Sub-Saharan Africa: A Systematic Review and Pooled Analysis (2010) (273)
A principal target of human immunity to malaria identified by molecular population genetic and immunological analyses (2000) (270)
A CD4+ T-cell immune response to a conserved epitope in the circumsporozoite protein correlates with protection from natural Plasmodium falciparum infection and disease (2004) (270)
Effect of vaccines on bacterial meningitis worldwide (2012) (268)
T-cell control of Epstein–Barr virus-infected B cells is lost during P. falciparum malaria (1984) (262)
Serogroup W135 meningococcal disease in Hajj pilgrims (2000) (260)
Absence of putative artemisinin resistance mutations among Plasmodium falciparum in Sub-Saharan Africa: a molecular epidemiologic study. (2015) (259)
High recombination rate in natural populations of Plasmodium falciparum. (1999) (259)
Severe malarial anemia and cerebral malaria are associated with different tumor necrosis factor promoter alleles. (1999) (259)
Averting a malaria disaster (1999) (256)
Poisoning by bites of the saw-scaled or carpet viper (Echis carinatus) in Nigeria. (1977) (256)
Use of clinical algorithms for diagnosing malaria 1 (2002) (252)
A trial of artemether or quinine in children with cerebral malaria. (1996) (251)
A Research Agenda for Malaria Eradication: Vaccines (2011) (248)
Effect of a serogroup A meningococcal conjugate vaccine (PsA–TT) on serogroup A meningococcal meningitis and carriage in Chad: a community study (2013) (247)
Comparison of two simple methods for determining malaria parasite density. (1991) (239)
IgG3 antibodies to Plasmodium falciparum merozoite surface protein 2 (MSP2): increasing prevalence with age and association with clinical immunity to malaria. (1998) (239)
Overlap in the clinical features of pneumonia and malaria in African children. (1993) (237)
Tumour necrosis factor production in Falciparum malaria and its association with schizont rupture. (1989) (234)
Immunogenicity of the RTS,S/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trial (2015) (233)
Placental malaria. I. Pathological classification (1993) (223)
Plasmodium falciparum malaria and Salmonella infections in Gambian children. (1987) (216)
TRIAL OF AN ATTENUATED BOVINE ROTAVIRUS VACCINE (RIT 4237) IN GAMBIAN INFANTS (1987) (214)
Efficacy and safety of intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in African infants: a pooled analysis of six randomised, placebo-controlled trials (2009) (212)
Seasonal intermittent preventive treatment with artesunate and sulfadoxine-pyrimethamine for prevention of malaria in Senegalese children: a randomised, placebo-controlled, double-blind trial (2006) (211)
Autoimmune disease and parasitic infections in Nigerians. (1968) (208)
Induction of immunologic memory in Gambian children by vaccination in infancy with a group A plus group C meningococcal polysaccharide-protein conjugate vaccine. (1997) (205)
IMPAIRMENT OF THE IMMUNE RESPONSE TO VACCINATION AFTER ACUTE MALARIA (1978) (205)
Manslaughter by Fake Artesunate in Asia—Will Africa Be Next? (2006) (204)
The effect of a monoclonal antibody to tumor necrosis factor on survival from childhood cerebral malaria. (1996) (200)
Rosette formation in Plasmodium falciparum isolates and anti-rosette activity of sera from Gambians with cerebral or uncomplicated malaria. (1992) (200)
Efficacy trial of malaria vaccine SPf66 in Gambian infants (1995) (198)
The etiology of pneumonia in malnourished and well-nourished Gambian children. (1994) (196)
Helicobacter pylori in Gambian children with chronic diarrhoea and malnutrition. (1990) (194)
Efficacy of artesunate plus pyrimethamine-sulphadoxine for uncomplicated malaria in Gambian children: a double-blind, randomised, controlled trial (2000) (192)
Review of Mass Drug Administration for Malaria and Its Operational Challenges (2015) (182)
The epidemiology of pneumococcal infection in children in the developing world. (1999) (181)
Cluster randomised trial of intermittent preventive treatment for malaria in infants in area of high, seasonal transmission in Ghana (2005) (179)
Possible role of a B-cell mitogen in hypergammaglobulinaemia in malaria and trypanosomiasis. (1974) (178)
Bacterial etiology of serious infections in young infants in developing countries: results of a multicenter study. The WHO Young Infants Study Group. (1999) (177)
Nasopharyngeal carriage of Streptococcus pneumoniae in Gambian infants: a longitudinal study. (2008) (176)
Control to elimination: implications for malaria research. (2008) (176)
A Randomised, Double-Blind, Controlled Vaccine Efficacy Trial of DNA/MVA ME-TRAP Against Malaria Infection in Gambian Adults (2004) (176)
Parasite virulence and disease patterns in Plasmodium falciparum malaria. (1994) (174)
Prevention of pneumococcal disease by vaccination: does serotype replacement matter? (2000) (171)
Predicting malaria infection in Gambian children from satellite data and bed net use surveys: the importance of spatial correlation in the interpretation of results. (1999) (170)
Nasopharyngeal carriage of Streptococcus pneumoniae in Gambian villagers. (2006) (170)
Permethrin-treated bed nets (mosquito nets) prevent malaria in Gambian children. (1988) (166)
The microepidemiology of malaria and its importance to malaria control. (1989) (165)
Mass administrations of antimalarial drugs. (2003) (162)
The effects of malaria chemoprophylaxis given by traditional birth attendants on the course and outcome of pregnancy. (1989) (160)
Nasopharyngeal carriage of pneumococci in Gambian children and in their families. (1996) (159)
Estimating the potential public health impact of seasonal malaria chemoprevention in African children (2012) (158)
Evidence for selection for the tyrosine-86 allele of the pfmdr 1 gene of Plasmodium falciparum by chloroquine and amodiaquine (1997) (158)
The effects of iron supplementation during pregnancy, given by traditional birth attendants, on the prevalence of anaemia and malaria. (1994) (157)
COMPARISON OF TWO STRATEGIES FOR CONTROL OF MALARIA WITHIN A PRIMARY HEALTH CARE PROGRAMME IN THE GAMBIA (1988) (157)
Carriage of Streptococcus pneumoniae and Other Respiratory Bacterial Pathogens in Low and Lower-Middle Income Countries: A Systematic Review and Meta-Analysis (2014) (154)
Iron, but not folic acid, combined with effective antimalarial therapy promotes haematological recovery in African children after acute falciparum malaria. (1995) (152)
Effect of the introduction of pneumococcal conjugate vaccination on invasive pneumococcal disease in The Gambia: a population-based surveillance study (2016) (151)
Seasonal variation of paediatric diseases in The Gambia, west Africa. (1993) (150)
Malaria in school-age children in Africa: an increasingly important challenge (2014) (149)
A prospective survey of the outcome of pregnancy in a rural area of the Gambia. (1987) (149)
Evaluation of an algorithm for the integrated management of childhood illness in an area with seasonal malaria in the Gambia. (1997) (148)
Identification of conserved antigenic components for a cytotoxic T lymphocyte-inducing vaccine against malaria (1995) (147)
High Resistance of Plasmodium falciparum to Sulphadoxine/Pyrimethamine in Northern Tanzania and the Emergence of dhps Resistance Mutation at Codon 581 (2009) (147)
Intermittent Preventive Treatment of Malaria Provides Substantial Protection against Malaria in Children Already Protected by an Insecticide-Treated Bednet in Mali: A Randomised, Double-Blind, Placebo-Controlled Trial (2011) (146)
Is there an interaction between human immunodeficiency virus and Plasmodium falciparum? (1998) (146)
HLA class I typing by PCR: HLA-B27 and an African B27 subtype (1991) (143)
Population genetics: Malaria susceptibility and CD36 mutation (2000) (141)
The molecular epidemiology of malaria (2002) (139)
Socio-economic risk factors for malaria in a peri-urban area of The Gambia. (1995) (138)
Etiology of acute lower respiratory tract infections in Gambian children: II. Acute lower respiratory tract infection in children ages one to nine years presenting at the hospital. (1991) (137)
Effect of Removing Direct Payment for Health Care on Utilisation and Health Outcomes in Ghanaian Children: A Randomised Controlled Trial (2009) (137)
Pathway to Deployment of Gene Drive Mosquitoes as a Potential Biocontrol Tool for Elimination of Malaria in Sub-Saharan Africa: Recommendations of a Scientific Working Group† (2018) (136)
Asymptomatic malaria infections--do they matter? (1987) (134)
Etiology of acute lower respiratory tract infections in Gambian children: I. Acute lower respiratory tract infections in infants presenting at the hospital. (1991) (132)
Deaths in infancy and early childhood in a well-vaccinated, rural, West African population. (1987) (132)
Pneumococcal disease among children in a rural area of west Africa. (1996) (132)
The epidemiology of multiple-clone Plasmodium falciparum infections in Gambian patients (1991) (129)
Serum IgG3 to the Plasmodium falciparum merozoite surface protein 2 is strongly associated with a reduced prospective risk of malaria (2003) (129)
Effects of Community-Wide Vaccination with PCV-7 on Pneumococcal Nasopharyngeal Carriage in The Gambia: A Cluster-Randomized Trial (2011) (128)
Attitudes to malaria, traditional practices and bednets (mosquito nets) as vector control measures: a comparative study in five west African countries. (1994) (127)
Plasmodium falciparum merozoite surface protein 3 is a target of allele-specific immunity and alleles are maintained by natural selection. (2007) (126)
Immunosuppression in murine malaria. I. General characteristics. (1971) (125)
Outcome of meningitis caused by Streptococcus pneumoniae and Haemophilus influenzae type b in children in The Gambia (2000) (125)
Epidemiologic and Clinical Characteristics of Community-Acquired Invasive Bacterial Infections in Children Aged 2–29 Months in The Gambia (2006) (125)
Changes in the pattern of infant and childhood mortality in Upper River Division, The Gambia, from 1989 to 1993 (1997) (122)
The limitations of verbal autopsy in a malaria-endemic region. (1994) (122)
Cell-mediated immunity during natural measles infection. (1978) (121)
Safety and efficacy of the RTS,S/AS01E candidate malaria vaccine given with expanded-programme-on-immunisation vaccines: 19 month follow-up of a randomised, open-label, phase 2 trial. (2011) (121)
Epidemiology of subpatent Plasmodium falciparum infection: implications for detection of hotspots with imperfect diagnostics (2013) (120)
The impact of a national impregnated bed net programme on the outcome of pregnancy in primigravidae in The Gambia. (1996) (119)
Epidemiology of malaria in the forest-savanna transitional zone of Ghana (2009) (119)
Eosinophilia and resistance to Schistosoma haematobium in man (1985) (119)
Immunosuppression in Gambian trypanosomiasis. (1973) (119)
The use of anti-malarial drugs to prevent malaria in the population of malaria-endemic areas. (2004) (119)
The etiology of lobar pneumonia in the Gambia. (1986) (118)
Placental malaria. II. A semi‐quantitative investigation of the pathological features (1993) (118)
Malaria eradication and elimination: views on how to translate a vision into reality (2015) (118)
Necrosis, haemorrhage and complement depletion following bites by the spitting cobra (Naja nigricollis). (1976) (118)
Intermittent Screening and Treatment versus Intermittent Preventive Treatment of Malaria in Pregnancy: A Randomised Controlled Non-Inferiority Trial (2010) (117)
Immune response to revaccination with meningococcal A and C polysaccharides in Gambian children following repeated immunisation during early childhood. (1999) (117)
Meningococcal carriage in the African meningitis belt. (2007) (117)
Suppression of cell-mediated immune responses to malaria antigens in pregnant Gambian women. (1989) (117)
A trial of bed nets (mosquito nets) as a malaria control strategy in a rural area of The Gambia, West Africa. (1988) (116)
Malaria prevalence is inversely related to vector density in The Gambia, West Africa. (1994) (116)
ASSESSMENT OF CLINICAL CRITERIA FOR IDENTIFICATION OF SEVERE ACUTE LOWER RESPIRATORY TRACT INFECTIONS IN CHILDREN (1989) (116)
Etiology of serious infections in young Gambian infants. (1999) (115)
A comparison of the efficacy of insecticide-treated and untreated bed nets in preventing malaria in Gambian children. (1995) (115)
A study of risk factors for pneumococcal disease among children in a rural area of west Africa. (1996) (115)
A malaria control trial using insecticide-treated bed nets and targeted chemoprophylaxis in a rural area of The Gambia, west Africa. 2. Mortality and morbidity from malaria in the study area. (1993) (115)
The epidemiology of infections due to Neisseria meningitidis and Neisseria lactamica in a northern Nigerian community. (1982) (114)
Association of Fcgamma receptor IIa (CD32) polymorphism with severe malaria in West Africa. (2003) (113)
Vaccination with a Haemophilus influenzae type b conjugate vaccine reduces oropharyngeal carriage of H. influenzae type b among Gambian children. (1998) (112)
Determinants of the accuracy of rapid diagnostic tests in malaria case management: evidence from low and moderate transmission settings in the East African highlands (2008) (112)
Ankylosing spondylitis in West Africans—evidence for a non-HLA-B27 protective effect (1997) (111)
A trial of permethrin-treated bed nets in the prevention of malaria in Gambian children. (1987) (111)
Rapid bacteriological diagnosis of pyogenic meningitis by latex agglutination. (1974) (111)
Meningococcal carriage, meningococcal disease and vaccination. (1988) (110)
An evaluation of the informed consent procedure used during a trial of a Haemophilus influenzae type B conjugate vaccine undertaken in The Gambia, West Africa. (1999) (110)
Gambian children successfully treated with chloroquine can harbor and transmit Plasmodium falciparum gametocytes carrying resistance genes. (2002) (110)
Malaria chemoprophylaxis, birth weight and child survival. (1992) (110)
Nutritional status of children admitted to hospital with different diseases and its relationship to outcome in The Gambia, West Africa (1998) (109)
Nutritional status of children admitted to hospital with different diseases and its relationship to outcome in The Gambia, West Africa (1998) (109)
BED-NETS (MOSQUITO-NETS) AND MORBIDITY FROM MALARIA (1986) (107)
Intermittent Preventive Treatment of Malaria Provides Substantial Protection against Malaria in Children Already Protected by an Insecticide-Treated Bednet in Burkina Faso: A Randomised, Double-Blind, Placebo-Controlled Trial (2011) (106)
A randomized controlled trial of artemether/benflumetol, a new antimalarial and pyrimethamine/sulfadoxine in the treatment of uncomplicated falciparum malaria in African children. (1998) (105)
Risk factors for mortality from acute lower respiratory tract infections in young Gambian children. (1993) (105)
Bites by the Saw-scaled or Carpet Viper (Echis carinatus): Trial of Two Specific Antivenoms (1974) (105)
Randomised trial of Haemophilus influenzae type-b tetanus protein conjugate vaccine [corrected] for prevention of pneumonia and meningitis in Gambian infants. (1997) (104)
Evaluation of a primary health care programme in The Gambia. I. The impact of trained traditional birth attendants on the outcome of pregnancy. (1990) (104)
Effectiveness of Seasonal Malaria Chemoprevention in Children under Ten Years of Age in Senegal: A Stepped-Wedge Cluster-Randomised Trial (2016) (104)
Plasmodium falciparum: the behavior of clinical isolates in an in vitro model of infected red blood cell sequestration. (1988) (104)
The pathogenesis of sleeping sickness. (1980) (104)
Estimates of the infectious reservoir of Plasmodium falciparum malaria in The Gambia and in Tanzania. (2000) (103)
The safety of the combination artesunate and pyrimethamine-sulfadoxine given during pregnancy. (2001) (103)
Mortality and morbidity from malaria after stopping malaria chemoprophylaxis. (1995) (103)
Counter-current immunoelectrophoresis in the diagnosis of meningococcal infections. (1971) (102)
Immunologic memory 5 years after meningococcal A/C conjugate vaccination in infancy. (2001) (102)
Aflatoxin exposure, malaria and hepatitis B infection in rural Gambian children. (1992) (101)
Protective efficacy and safety of three antimalarial regimens for intermittent preventive treatment for malaria in infants: a randomised, double-blind, placebo-controlled trial (2009) (101)
Seasonal Intermittent Preventive Treatment for the Prevention of Anaemia and Malaria in Ghanaian Children: A Randomized, Placebo Controlled Trial (2008) (100)
Impact of permethrin‐treated bednets on malaria transmission by the Anopheles gambiae complex in The Gambia (1989) (100)
Review: Intermittent preventive treatment – a new approach to the prevention of malaria in children in areas with seasonal malaria transmission (2006) (100)
The effects on malaria of treatment of iron-deficiency anaemia with oral iron in Gambian children. (1989) (100)
Prevention of secondary cases of meningococcal disease in household contacts by vaccination. (1978) (100)
MENINGOCOCCAL DISEASE AND SEASON IN SUB-SAHARAN AFRICA (1984) (100)
The relationship between anthropometric measurements and measurements of iron status and susceptibility to malaria in Gambian children. (1991) (100)
Pilot trial of a pentavalent pneumococcal polysaccharide/protein conjugate vaccine in Gambian infants. (1996) (99)
Patterns and seasonality of malaria transmission in the forest-savannah transitional zones of Ghana (2010) (99)
Predictors of a fatal outcome following childhood cerebral malaria. (1997) (98)
Host haematological factors influencing the transmission of Plasmodium falciparum gametocytes to Anopheles gambiae s.s. mosquitoes (1999) (98)
Clinical predictors of hypoxaemia in Gambian children with acute lower respiratory tract infection: prospective cohort study (1999) (97)
Cellular immune responses to Plasmodium falciparum antigens in Gambian children during and after an acute attack of falciparum malaria. (1988) (97)
Importance of enteric bacteria as a cause of pneumonia, meningitis and septicemia among children in a rural community in The Gambia, West Africa (1994) (97)
A clinical algorithm for the diagnosis of malaria: results of an evaluation in an area of low endemicity (2001) (96)
Risk factors for gametocyte carriage in Gambian children. (2001) (96)
The clinical spectrum of respiratory syncytial virus disease in The Gambia. (1998) (96)
Epidemiology and clinical presentation of respiratory syncytial virus infection in a rural area of southern Mozambique (2002) (96)
A longitudinal study of naturally acquired cellular and humoral immune responses to a merozoite surface protein (MSP1) of Plasmodium falciparum in an area of seasonal malaria transmission (1993) (95)
The safety of artemisinins during pregnancy: a pressing question (2007) (95)
The effects of hemoglobin genotype and ABO blood group on the formation of rosettes by Plasmodium falciparum-infected red blood cells. (1993) (95)
MORTALITY FROM PNEUMOCOCCAL MENINGITIS (1976) (95)
Epidemiology of invasive pneumococcal disease in the Western Region, The Gambia. (1998) (94)
Editorial: 100 years of epidemic meningitis in West Africa – has anything changed? (2006) (94)
Chloroquine treatment of severe malaria in children. Pharmacokinetics, toxicity, and new dosage recommendations. (1988) (94)
Malaria in a peri-urban area of The Gambia. (1990) (93)
A Trial of the Efficacy, Safety and Impact on Drug Resistance of Four Drug Regimens for Seasonal Intermittent Preventive Treatment for Malaria in Senegalese Children (2008) (92)
Pneumococcal antigen in lobar pneumonia. (1975) (92)
A malaria control trial using insecticide-treated bed nets and targeted chemoprophylaxis in a rural area of The Gambia, west Africa. 3. Entomological characteristics of the study area. (1993) (91)
Immunization with a pneumococcal capsular polysaccharide vaccine during pregnancy. (1996) (91)
Comparison of bednets impregnated with different pyrethroids for their impact on mosquitoes and on re-infection with malaria after clearance of pre-existing infections with chlorproguanil-dapsone. (1999) (91)
Can malaria be eliminated? (2009) (90)
Clonal and variable properties of Neisseria meningitidis isolated from cases and carriers during and after an epidemic in The Gambia, West Africa. (1989) (90)
Interethnic genetic differentiation in Africa: HLA class I antigens in The Gambia. (1992) (90)
Maternal immunization with Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine in The Gambia. (1996) (90)
A phase I safety and immunogenicity trial with the candidate malaria vaccine RTS,S/SBAS2 in semi-immune adults in The Gambia. (1999) (90)
The future of immunisation policy, implementation, and financing (2011) (89)
A Decline in the Incidence of Invasive Non-Typhoidal Salmonella Infection in the Gambia Temporally Associated with a Decline in Malaria Infection (2010) (89)
The effect of mass administration of sulfadoxine-pyrimethamine combined with artesunate on malaria incidence: a double-blind, community-randomized, placebo-controlled trial in The Gambia. (2003) (89)
Increased plasma concentrations of sICAM-1, sVCAM-1 and sELAM-1 in patients with Plasmodium falciparum or P. vivax malaria and association with disease severity. (1994) (89)
A malaria control trial using insecticide-treated bed nets and targeted chemoprophylaxis in a rural area of The Gambia, west Africa. 7. Impact of permethrin-impregnated bed nets on malaria vectors. (1993) (89)
Prevention of malaria in pregnancy. (2018) (89)
Treatment of African children with uncomplicated falciparum malaria with a new antimalarial drug, CGP 56697. (1997) (88)
Carriage of group B Streptococci in pregnant Gambian mothers and their infants. (1994) (88)
The epidemiology of Haemophilus influenzae meningitis in children under five years of age in The Gambia, West Africa. (1990) (88)
FAILURE TO DETECT ENDOTOXIN IN SERUM OF CHILDREN WITH MALARIA (1975) (88)
The age patterns of severe malaria syndromes in sub-Saharan Africa across a range of transmission intensities and seasonality settings (2010) (88)
Persistent measles infection in malnourished children. (1977) (88)
Pneumococcal vaccination in developing countries (2006) (88)
Transmission of Streptococcus pneumoniae in rural Gambian villages: a longitudinal study. (2010) (87)
Protective efficacy of the RTS,S/AS02 Plasmodium falciparum malaria vaccine is not strain specific. (2003) (86)
Nasopharyngeal Carriage of Streptococcus pneumoniae in Gambian Children who Participated in a 9-valent Pneumococcal Conjugate Vaccine Trial and in Their Younger Siblings (2009) (86)
Malaria vaccines and their potential role in the elimination of malaria (2008) (86)
Population at risk. (1990) (85)
Disruption of Plasmodium falciparum erythrocyte rosettes by standard heparin and heparin devoid of anticoagulant activity. (1992) (85)
Intermittent preventive treatment for malaria in pregnancy in Africa: What's new, what's needed? (2007) (84)
Safety and immunogenicity of a nonavalent pneumococcal vaccine conjugated to CRM197 administered simultaneously but in a separate syringe with diphtheria, tetanus and pertussis vaccines in Gambian infants (2000) (84)
Variation in Toll-like receptor 4 and susceptibility to group a meningococcal meningitis in Gambian children (2003) (84)
Two Strategies for the Delivery of IPTc in an Area of Seasonal Malaria Transmission in The Gambia: A Randomised Controlled Trial (2011) (84)
Azithromycin-chloroquine and the intermittent preventive treatment of malaria in pregnancy (2008) (83)
A randomized trial of chloroquine, amodiaquine and pyrimethamine‐sulphadoxine in Gambian children with uncomplicated malaria (1996) (83)
A glycoprotein pneumococcal conjugate vaccine primes for antibody responses to a pneumococcal polysaccharide vaccine in Gambian children. (1997) (83)
Malaria chemoprophylaxis with chloroquine in young Nigerian children. IV. Its effect on haematological measurements. (1985) (82)
Serotype and antimicrobial susceptibility patterns of isolates of Streptococcus pneumoniae causing invasive disease in The Gambia 1996–2003 (2006) (82)
Bacterial isolates from blood and lung aspirate cultures in Gambian children with lobar pneumonia. (1997) (82)
Impact of the introduction of pneumococcal conjugate vaccination on pneumonia in The Gambia: population-based surveillance and case-control studies (2017) (82)
Failure of cytotoxic drugs to suppress immune responses of patients with rheumatoid arthritis. (1970) (81)
An epidemic of meningococcal infection at Zaria, Northern Nigeria. 1. General epidemiological features. (1979) (80)
An epidemiological study of RSV infection in the Gambia. (2002) (80)
Suppressed peripheral and placental blood lymphoproliferative responses in first pregnancies: relevance to malaria. (1993) (80)
A malaria control trial using insecticide-treated bed nets and targeted chemoprophylaxis in a rural area of The Gambia, west Africa. 5. Design and implementation of the trial. (1993) (80)
Evaluation of Binax now Streptococcus pneumoniae urinary antigen test in children in a community with a high carriage rate of pneumococcus. (2001) (80)
Allergic Complications of Meningococcal Disease II—Immunological Investigations (1973) (80)
Predictors of mortality in Gambian children with severe malaria anaemia. (1997) (79)
Ethnic differences in the prevalence of splenomegaly and malaria in The Gambia. (1987) (79)
Recognition of dominant T cell-stimulating epitopes from the circumsporozoite protein of Plasmodium falciparum and relationship to malaria morbidity in Gambian children. (1990) (79)
Randomized Controlled Trial of RTS,S/AS02D and RTS,S/AS01E Malaria Candidate Vaccines Given According to Different Schedules in Ghanaian Children (2009) (79)
Long-Term Impact of Malaria Chemoprophylaxis on Cognitive Abilities and Educational Attainment: Follow-Up of a Controlled Trial (2006) (79)
Meningitis caused by a serogroup W135 clone of the ET‐37 complex of Neisseria meningitidis in West Africa (1998) (79)
The Diversity of Meningococcal Carriage Across the African Meningitis Belt and the Impact of Vaccination With a Group A Meningococcal Conjugate Vaccine (2015) (78)
Comparison of artemether and chloroquine for severe malaria in Gambian children (1992) (78)
Relationships between maternal malaria and malarial immune responses in mothers and neonates (1995) (78)
Responses of Anopheles gambiae complex mosquitoes to the use of untreated bednets in The Gambia (1989) (78)
Chloroquine prophylaxis against vivax malaria in pregnancy: a randomized, double‐blind, placebo‐controlled trial (2007) (78)
Neonatal mortality in a rural area of The Gambia. (1999) (78)
Efficacy, safety, and tolerability of amodiaquine plus sulphadoxine-pyrimethamine used alone or in combination for malaria treatment in pregnancy: a randomised trial (2006) (78)
Polyarthritis in Western Nigeria. I. Rheumatoid arthritis. (1969) (78)
Morbidity from malaria and immune responses to defined Plasmodium falciparum antigens in children with sickle cell trait in The Gambia. (1992) (77)
Randomized Trial of Piperaquine with Sulfadoxine-Pyrimethamine or Dihydroartemisinin for Malaria Intermittent Preventive Treatment in Children (2009) (77)
Immune response to soluble exoantigens of Plasmodium falciparum may contribute to both pathogenesis and protection in clinical malaria: evidence from a longitudinal, prospective study of semi‐immune African children (1991) (76)
CONTROL OF MENINGOCOCCAL INFECTION IN THE AFRICAN MENINGITIS BELT BY SELECTIVE VACCINATION (1980) (75)
Malaria chemoprophylaxis, infection of the placenta and birth weight in Gambian primigravidae. (1994) (75)
Clinical predictors of malaria in Gambian children with fever or a history of fever. (1998) (74)
Global incidence of serogroup B invasive meningococcal disease: a systematic review. (2015) (73)
A global action plan for the prevention and control of pneumonia. (2008) (73)
Socio-economic determinants are not major risk factors for severe malaria in Gambian children. (1995) (73)
RTS,S/AS02A Malaria Vaccine Does Not Induce Parasite CSP T Cell Epitope Selection and Reduces Multiplicity of Infection (2006) (73)
Complement activation in children with acute malaria. (1974) (72)
A malaria control trial using insecticide-treated bed nets and targeted chemoprophylaxis in a rural area of The Gambia, west Africa. 1. A review of the epidemiology and control of malaria in The Gambia, west Africa. (1993) (72)
Power, fairness and trust: understanding and engaging with vaccine trial participants and communities in the setting up the EBOVAC-Salone vaccine trial in Sierra Leone (2016) (72)
The development of Lapdap, an affordable new treatment for malaria. (2003) (72)
Prevention of Ebola virus disease through vaccination: where we are in 2018 (2018) (72)
Anti-malarial drugs and the prevention of malaria in the population of malaria endemic areas (2010) (71)
Factors influencing susceptibility to meningococcal disease during an epidemic in The Gambia, West Africa. (1987) (70)
MENINGOCOCCAL DISEASE AND SEASON IN SUB-SAHARAN AFRICA (1985) (70)
Agglutination of Plasmodium falciparum-infected erythrocytes from east and west African isolates by human sera from distant geographic regions. (1992) (69)
A prospective evaluation of a clinical algorithm for the diagnosis of malaria in Gambian children (2000) (69)
Intermittent screening and treatment versus intermittent preventive treatment of malaria in pregnancy: user acceptability (2010) (69)
Polymorphism of the Pfmdr1 gene and chloroquine resistance in Plasmodium falciparum in The Gambia. (1997) (69)
Clinical prediction of serious bacterial infections in young infants in developing countries. The WHO Young Infants Study Group. (1999) (69)
Selective primary health care: strategies for control of disease in the developing world. XIII. Acute bacterial meningitis. (1984) (68)
Use of simple clinical signs to predict pneumonia in young Gambian children: the influence of malnutrition. (1995) (68)
Allergic Complications of Meningococcal Disease I—Clinical Aspects (1973) (68)
Risk factors for severe respiratory syncytial virus infection leading to hospital admission in children in the Western Region of The Gambia. (1999) (68)
Malaria vaccines and the new malaria agenda. (2011) (67)
Chlorproguanil−Dapsone−Artesunate versus Artemether−Lumefantrine: A Randomized, Double-Blind Phase III Trial in African Children and Adolescents with Uncomplicated Plasmodium falciparum Malaria (2009) (67)
Malaria in pregnancy: priorities for research. (2007) (67)
Repeat Sequences in Block 2 of Plasmodium falciparum Merozoite Surface Protein 1 Are Targets of Antibodies Associated with Protection from Malaria (2003) (67)
Evaluation of the safety and immunogenicity of the RTS,S/AS01E malaria candidate vaccine when integrated in the expanded program of immunization. (2010) (67)
The Gambian National Impregnated Bednet Programme: costs, consequences and net cost-effectiveness. (1998) (66)
An improved microassay for Plasmodium falciparum cytoadherence using stable transformants of Chinese hamster ovary cells expressing CD36 or intercellular adhesion molecule-1. (1993) (66)
Movement of Anopheles gambiae s.l. malaria vectors between villages in The Gambia (1995) (66)
T and B cell responses of Plasmodium falciparum malaria-immune individuals to synthetic peptides corresponding to sequences in different regions of the P. falciparum antigen Pf155/RESA. (1989) (66)
Association between immune recognition of the malaria vaccine candidate antigen Pf155/RESA and resistance to clinical disease: a prospective study in a malaria-endemic region of west Africa. (1991) (66)
Efficacy of a novel, protein-based pneumococcal vaccine against nasopharyngeal carriage of Streptococcus pneumoniae in infants: A phase 2, randomized, controlled, observer-blind study. (2017) (65)
Management of severe malarial anaemia in Gambian children. (1997) (65)
Seasonality and outbreak of a predominant Streptococcus pneumoniae serotype 1 clone from The Gambia: Expansion of ST217 hypervirulent clonal complex in West Africa (2008) (65)
Epidemiological changes in meningococcal meningitis in Niger from 2008 to 2011 and the impact of vaccination (2013) (65)
The effect of dose on the antimalarial efficacy of artemether-lumefantrine: a systematic review and pooled analysis of individual patient data. (2015) (65)
Molecular epidemiology of community-acquired invasive non-typhoidal Salmonella among children aged 2 29 months in rural Gambia and discovery of a new serovar, Salmonella enterica Dingiri. (2007) (65)
The epidemiology of meningococcal disease in India (2010) (65)
Longitudinal study of Plasmodium falciparum polymorphic antigens in a malaria-endemic population (1992) (64)
Etiology of acute lower respiratory tract infections in children in a rural community in The Gambia (1992) (64)
Malaria chemoprophylaxis with chloroquine in young Nigerian children. III. Its effect on nutrition. (1985) (64)
Suppression of Autoimmune Disease in NZB and (NZB×NZW)F1 Hybrid Mice by Infection with Malaria (1970) (64)
Antischistosomal efficacy of artesunate combination therapies administered as curative treatments for malaria attacks. (2007) (64)
A malaria control trial using insecticide-treated bed nets and targeted chemoprophylaxis in a rural area of The Gambia, west Africa. 4. Perceptions of the causes of malaria and of its treatment and prevention in the study area. (1993) (64)
Permethrin-treated bed nets do not have a 'mass-killing effect' on village populations of Anopheles gambiae s.l. in The Gambia. (1998) (64)
A randomized, controlled trial of intermittent preventive treatment with sulfadoxine-pyrimethamine, amodiaquine, or the combination in pregnant women in Ghana. (2008) (63)
Impact of asymptomatic malaria parasitaemia on cognitive function and school achievement of schoolchildren in the Yemen Republic (2000) (62)
Hot spot or not: a comparison of spatial statistical methods to predict prospective malaria infections (2014) (62)
Systematic review: Impact of meningococcal vaccination on pharyngeal carriage of meningococci (2007) (61)
Randomized Trial of Artesunate+Amodiaquine, Sulfadoxine-Pyrimethamine+Amodiaquine, Chlorproguanal-Dapsone and SP for Malaria in Pregnancy in Tanzania (2009) (61)
Association of hepatitis B surface antigen carriage with severe malaria in Gambian children (1995) (61)
T Cell Responses to the RTS,S/AS01E and RTS,S/AS02D Malaria Candidate Vaccines Administered According to Different Schedules to Ghanaian Children (2011) (61)
Barriers to timely administration of birth dose vaccines in The Gambia, West Africa (2016) (61)
Geographical perspectives on bednet use and malaria transmission in The Gambia, West Africa. (1996) (60)
A randomized, placebo‐controlled trial of intermittent preventive treatment with sulphadoxine–pyrimethamine in Gambian multigravidae (2006) (60)
Sustained protection against mortality and morbidity from malaria in rural Gambian children by chemoprophylaxis given by village health workers. (1990) (60)
The immune response to a meningococcal polysaccharide vaccine in an African village. (1980) (60)
An epidemic of meningococcal infection at Zaria, Northern Nigeria. 3. Meningococcal carriage. (1979) (60)
Increased concentrations of interleukin-6 and interleukin-1 receptor antagonist and decreased concentrations of beta-2-glycoprotein I in Gambian children with cerebral malaria (1994) (60)
Etiology of Severe Childhood Pneumonia in The Gambia, West Africa, Determined by Conventional and Molecular Microbiological Analyses of Lung and Pleural Aspirate Samples (2014) (60)
Resistance to reinfection with Schistosoma haematobium in Gambian children: analysis of their immune responses. (1987) (60)
A Non-Inferiority, Individually Randomized Trial of Intermittent Screening and Treatment versus Intermittent Preventive Treatment in the Control of Malaria in Pregnancy (2015) (59)
Likely Health Outcomes for Untreated Acute Febrile Illness in the Tropics in Decision and Economic Models; A Delphi Survey (2011) (59)
Evaluation of vaccines for the prevention of pneumonia in children in developing countries. (1999) (59)
Haemophilus influenzae type b meningitis in The Gambia after introduction of a conjugate vaccine (1999) (59)
Effects of azithromycin on malariometric indices in The Gambia (1995) (59)
Influence of wasting and stunting at the onset of the rainy season on subsequent malaria morbidity among rural preschool children in Senegal. (2009) (59)
The pattern of infant and childhood mortality in Upper River Division, The Gambia. (1993) (58)
Seasonal Malaria Vaccination with or without Seasonal Malaria Chemoprevention. (2021) (58)
A trial of Fansidar plus chloroquine or Fansidar alone for the treatment of uncomplicated malaria in Gambian children. (1998) (58)
Partial characterization of a malaria mitogen. (1979) (58)
Do we still need a malaria vaccine? (2009) (58)
Auto-immune aspects of myasthenia gravis. (1966) (57)
Demonstration during life of rabies antigen in humans. (1975) (57)
Treatment of Chronic Asymptomatic Plasmodium falciparum Infection Does Not Increase the Risk of Clinical Malaria Upon Reinfection (2017) (57)
Science and Technology for Disease Control: Past, Present, and Future (2006) (57)
Malaria and splenomegaly. (1983) (56)
Effect of Age and Vaccination With a Pneumococcal Conjugate Vaccine on the Density of Pneumococcal Nasopharyngeal Carriage (2012) (56)
Malaria vaccines. Evaluation and implementation. (2005) (56)
Anti-sporozoite antibodies and immunity to malaria in a rural Gambian population. (1988) (56)
An Open Label, Randomised Trial of Artesunate+Amodiaquine, Artesunate+Chlorproguanil-Dapsone and Artemether-Lumefantrine for the Treatment of Uncomplicated Malaria (2008) (56)
Epidemiology and clinical features of pneumonia according to radiographic findings in Gambian children (2007) (55)
Severe malaria in children in Yemen: two site observational study (2006) (55)
SIMPLE CLINICAL SIGNS FOR DIAGNOSIS OF ACUTE LOWER RESPIRATORY INFECTIONS (1988) (55)
Housing and child health in sub-Saharan Africa: A cross-sectional analysis (2020) (55)
Cerebrospinal-fluid IgM in patients with sleeping-sickness. (1973) (55)
Entomological risk factors for severe malaria in a peri-urban area of The Gambia. (1993) (55)
Chloroquine or amodiaquine combined with sulfadoxine-pyrimethamine as a treatment for uncomplicated malaria--a systematic review. (1998) (54)
The epidemiology of malaria in adults in a rural area of southern Mozambique (2007) (54)
MHC and malaria: the relationship between HLA class II alleles and immune responses to Plasmodium falciparum. (1992) (54)
Pallor as a clinical sign of severe anaemia in children: an investigation in the Gambia. (1997) (53)
Influence of malaria transmission intensity and the 581G mutation on the efficacy of intermittent preventive treatment in pregnancy: systematic review and meta‐analysis (2015) (53)
Malaria in a rural area of Sierra Leone. III. Vector ecology and disease transmission. (1994) (53)
C-reactive protein and haptoglobin in the evaluation of a community-based malaria control programme. (1996) (53)
Changing pattern of malaria in Bissau, Guinea Bissau (2008) (53)
Human retroviral infections in The Gambia: prevalence and clinical features (1988) (53)
Randomized Noninferiority Trial of Dihydroartemisinin-Piperaquine Compared with Sulfadoxine-Pyrimethamine plus Amodiaquine for Seasonal Malaria Chemoprevention in Burkina Faso (2015) (53)
The epidemiology of malaria. (1997) (52)
Immunogenicity and serotype-specific efficacy of a 9-valent pneumococcal conjugate vaccine (PCV-9) determined during an efficacy trial in The Gambia. (2008) (52)
TRIAL OF CO-TRIMOXAZOLE VERSUS PROCAINE PENICILLIN WITH AMPICILLIN IN TREATMENT OF COMMUNITY-ACQUIRED PNEUMONIA IN YOUNG GAMBIAN CHILDREN (1988) (52)
Molecular epidemiology of pneumococci obtained from Gambian children aged 2–29 months with invasive pneumococcal disease during a trial of a 9-valent pneumococcal conjugate vaccine (2008) (52)
Cell-mediated immune responses to Plasmodium falciparum antigens in adult Gambians. (1988) (52)
Detection of Streptococcus pneumoniae DNA in blood cultures by PCR (1994) (52)
A Randomised Trial to Compare the Safety, Tolerability and Efficacy of Three Drug Combinations for Intermittent Preventive Treatment in Children (2010) (51)
Cellular mechanisms involved in recovery from acute malaria in Gambian children (1986) (51)
A Gambian Infant with Fever and an Unexpected Blood Film (2006) (51)
Evaluation of a primary health care programme in The Gambia. II. Its impact on mortality and morbidity in young children. (1990) (51)
Anopheles gambiae gonotrophic cycle duration, biting and exiting behaviour unaffected by permethrin‐impregnated bednets in The Gambia (1997) (51)
Duration of Protection against Malaria and Anaemia Provided by Intermittent Preventive Treatment in Infants in Navrongo, Ghana (2008) (51)
Sequelae of epidemic meningococcal meningitis in Africa. (1988) (50)
Severe malaria in Gambian children is not due to lack of previous exposure to malaria (1992) (50)
Changes in Malaria Parasite Drug Resistance in an Endemic Population Over a 25-Year Period With Resulting Genomic Evidence of Selection (2013) (50)
The effect of temperature reduction on respiratory rate in febrile illnesses. (1993) (49)
Biochemical evidence of muscle injury in African children with severe malaria. (1989) (49)
A trial of intermittent preventive treatment and home-based management of malaria in a rural area of The Gambia (2011) (48)
Failure of meningococcal vaccination to stop the transmission of meningococci in Nigerian schoolboys. (1983) (48)
Complement and meningococcal infection. (1976) (48)
Suppression of autoimmune disease in NZB and (NZB x NZW) F1 hybrid mice by infection with malaria. (1970) (48)
Effect on nasopharyngeal pneumococcal carriage of replacing PCV7 with PCV13 in the Expanded Programme of Immunization in The Gambia (2015) (48)
Lymphocyte changes in acute malaria. (1977) (48)
Can Parasitic Infection Suppress Autoimmune Disease? (1970) (48)
The Gambian National Impregnated Bed Net Programme: evaluation of effectiveness by means of case-control studies. (1997) (47)
Sequence diversity of TT virus in geographically dispersed human populations. (1999) (47)
In vitro rosetting, cytoadherence, and microagglutination properties of Plasmodium falciparum-infected erythrocytes from Gambian and Tanzanian patients (1990) (46)
Malaria transmission and vector control. (1997) (46)
Malaria Policy Advisory Committee to the WHO: conclusions and recommendations of sixth biannual meeting (September 2014) (2015) (46)
Effects of measles on the immune response of Nigerian children (1973) (46)
Who should be prioritised for COVID-19 vaccination? (2020) (46)
Serotype-Specific Pneumococcal Antibodies in Breast Milk of Gambian Women Immunized With a Pneumococcal Polysaccharide Vaccine During Pregnancy (2004) (46)
Chloroquine pharmacokinetics in pregnant and nonpregnant women with vivax malaria (2008) (46)
Antibody response to pneumococcal capsular polysaccharide vaccine in African children. (1991) (45)
Pneumococcal meningitis: a clinical and laboratory study. (1976) (45)
Pharyngeal carriage of Neisseria species in the African meningitis belt (2016) (45)
Efficacy of amodiaquine, sulphadoxine-pyrimethamine and their combination for the treatment of uncomplicated Plasmodium falciparum malaria in children in Cameroon at the time of policy change to artemisinin-based combination therapy (2010) (45)
Mefloquine safety and tolerability in pregnancy: a systematic literature review (2014) (45)
Entomological evaluation of the Gambia's National Impregnated Bednet Programme. (1995) (45)
Anti-phospholipid antibodies in patients with Plasmodium falciparum malaria. (1993) (45)
Nationwide survey of bednet use in rural Gambia. (1994) (45)
Trends in multiplicity of Plasmodium falciparum infections among asymptomatic residents in the middle belt of Ghana (2013) (45)
Single injection treatment of meningococcal meningitis. 2. Long-acting chloramphenicol. (1979) (45)
Latex agglutination test for diagnosing pneumococcal pneumonia in children in developing countries. (1989) (45)
Placental malaria and the risk of malaria in infants in a high malaria transmission area in ghana: a prospective cohort study. (2013) (44)
Options for the Delivery of Intermittent Preventive Treatment for Malaria to Children: A Community Randomised Trial (2009) (44)
Why is malaria fever periodic? A hypothesis. (1989) (44)
Strain variation in tumor necrosis factor induction by parasites from children with acute falciparum malaria (1995) (44)
High-throughput sequence typing of T-cell epitope polymorphisms in Plasmodium falciparum circumsporozoite protein. (2000) (44)
Permethrin‐impregnated bednets reduce nuisance arthropods in Gambian houses (1989) (44)
Immunosuppression in murine malaria. II. The effect on reticulo-endothelial and germinal centre function. (1971) (44)
Breast cancer: causes of patients' distress identified by qualitative analysis. (1994) (44)
Serology describes a profile of declining malaria transmission in Farafenni, The Gambia (2015) (44)
Modelling the Epidemiological Impact of Intermittent Preventive Treatment against Malaria in Infants (2008) (43)
Respiratory illness after severe respiratory syncytial virus disease in infancy in The Gambia. (1999) (43)
Monitoring the Introduction of Pneumococcal Conjugate Vaccines into West Africa: Design and Implementation of a Population-Based Surveillance System (2012) (43)
Meningococcal antibody titres in infants of women immunised with meningococcal polysaccharide vaccine during pregnancy. (1996) (43)
Parasite infectivity and immunity to Plasmodium falciparum gametocytes in Gambian children (2004) (42)
The impact of charging for insecticide on the Gambian National Impregnated Bednet Programme. (1997) (42)
Cost Effectiveness of Seasonal Intermittent Preventive Treatment Using Amodiaquine & Artesunate or Sulphadoxine-Pyrimethamine in Ghanaian Children (2010) (42)
Carriage of serogroup W-135, ET-37 meningococci in The Gambia: implications for immunisation policy? (2000) (42)
Mortality from meningococcal disease during an epidemic in The Gambia, West Africa. (1987) (42)
Effect of Adding Azithromycin to Seasonal Malaria Chemoprevention. (2019) (42)
Malaria chemoprophylaxis with chloroquine in young Nigerian children. I. Its effect on mortality, morbidity and the prevalence of malaria. (1985) (42)
Immunity to malaria in young Gambian children after a two-year period of chemoprophylaxis. (1988) (42)
"We are the heroes because we are ready to die for this country": Participants' decision-making and grounded ethics in an Ebola vaccine clinical trial. (2018) (41)
Epidemiology of acute lower respiratory tract infections, especially those due to Haemophilus influenzae type b, in The Gambia, west Africa. (1992) (41)
Rheumatoid factor in Nigerian sera. (1971) (41)
The response to iron supplementation of pregnant women with the haemoglobin genotype AA or AS. (1995) (41)
Priorities for research on meningococcal disease and the impact of serogroup A vaccination in the African meningitis belt. (2013) (40)
Haemophilus influenzae type b disease in the western region of The Gambia: background surveillance for a vaccine efficacy trial. (1996) (40)
Plasmodium falciparum: intragenic recombination and nonrandom associations between polymorphic domains of the precursor to the major merozoite surface antigens. (1991) (40)
Use of insecticide-impregnated bed nets in Gambian primary health care: economic aspects. (1989) (40)
Neglected tropical diseases and the Global Fund (2009) (40)
Maternal immunisation in developing countries. (2003) (40)
Seasonality in malaria transmission: implications for case-management with long-acting artemisinin combination therapy in sub-Saharan Africa (2015) (39)
The accuracy of the clinical histories given by mothers of seriously ill African children. (1987) (39)
Maternal administration of chloroquine: an unexplored aspect of malaria control. (1988) (39)
Cellular immune responses to Plasmodium falciparum antigens in children receiving long term anti-malarial chemoprophylaxis. (1989) (39)
Trial of Chloramphenicol for Meningitis in Northern Savanna of Africa (1973) (39)
The Gambian National Impregnated Bednet Programme: evaluation of the 1994 cost recovery trial. (1997) (39)
Timing of serotype 1 pneumococcal disease suggests the need for evaluation of a booster dose. (2011) (39)
Accelerating vaccine development and deployment: report of a Royal Society satellite meeting (2011) (39)
Increased plasma levels of soluble IL‐2R are associated with severe Plasmodium falciparum malaria (1994) (39)
Sampling methods to detect carriage of Neisseria meningitidis; literature review. (2009) (39)
Immunology of medicine in the tropics (1981) (39)
Malaria Policy Advisory Committee to the WHO: conclusions and recommendations of March 2013 meeting (2013) (39)
Community perceptions of a mass administration of an antimalarial drug combination in The Gambia (2001) (38)
IgM and antibody measurement in the diagnosis and management of Gambian trypanosomiasis. (1977) (38)
Comparative study of group A and group C meningococcal infection. (1977) (38)
Speckled antinuclear factor in African sera. (1970) (38)
Malaria--a Shadow over Africa (2002) (38)
Reaching Millennium Development Goal 4 – The Gambia (2011) (38)
Between hope and a hard place (2004) (37)
Childhood pneumonia: preventing the world’s biggest killer of children (2007) (37)
The distribution of birth weights in Gambian women who received malaria chemoprophylaxis during their first pregnancy and in control women. (1994) (37)
Meningococcal antigen in diagnosis and treatment of group A meningococcal infections. (1975) (37)
The Performance of a Rapid Diagnostic Test in Detecting Malaria Infection in Pregnant Women and the Impact of Missed Infections (2015) (37)
Malaria mortality and morbidity in Africa. (1999) (37)
Single injection treatment of meningococcal meningitis. 1. Long-acting penicillin. (1979) (37)
The epidemiology of malaria among pregnant women attending antenatal clinics in an area with intense and highly seasonal malaria transmission in northern Ghana (2009) (37)
Sequence analysis of HLA-Bw53, a common West African allele, suggests an origin by gene conversion of HLA-B35. (1991) (36)
A mathematical model of serotype replacement in pneumococcal carriage following vaccination (2013) (36)
Complement activation in patients with Gambian sleeping sickness. (1976) (36)
Intermittent Screening and Treatment versus Intermittent Preventive Treatment of Malaria in Pregnancy: Provider Knowledge and Acceptability (2011) (36)
Malaria in a rural area of Sierra Leone. I. Initial results. (1993) (36)
Levels of tumour necrosis factor and soluble TNF receptors during malaria fever episodes in the community. (1998) (35)
Clinical predictors of bacterial meningitis in infants and young children in The Gambia (2002) (35)
Detection of Haemophilus influenzae and Streptococcus pneumoniae DNA in blood culture by a single PCR assay (1996) (35)
New malaria-control policies and child mortality in senegal: reaching millennium development goal 4. (2012) (35)
Malaria chemoprophylaxis with chloroquine in young Nigerian children. II. Effect on the immune response to vaccination. (1985) (35)
Performance of the OptiMAL® dipstick in the diagnosis of malaria infection in pregnancy (2008) (35)
Malaria in a rural area of Sierra Leone. II. Parasitological and related results from pre- and post-rains clinical surveys. (1993) (35)
Continuing Effectiveness of Serogroup A Meningococcal Conjugate Vaccine, Chad, 2013 (2015) (35)
Effects of misclassification of causes of death on the power of a trial to assess the efficacy of a pneumococcal conjugate vaccine in The Gambia. (2003) (35)
Reactogenicity, safety and immunogenicity of a protein-based pneumococcal vaccine in Gambian children aged 2–4 years: A phase II randomized study (2015) (35)
Can malaria chemoprophylaxis be restricted to first pregnancies? (1994) (35)
Intermittent preventive antimalarial treatment in infants. (2007) (34)
Vaccines against encapsulated bacteria: a global agenda. (1987) (34)
PNEUMOCOCCAL SEROTYPES IN WEST AFRICA (1980) (34)
Immunodiagnosis of Snake Bite (1974) (34)
Measuring morbidity from malaria. (1989) (34)
Vaccines and global health (2011) (34)
Indirect Effect of 7-Valent Pneumococcal Conjugate Vaccine on Pneumococcal Carriage in Newborns in Rural Gambia: A Randomised Controlled Trial (2012) (33)
Carriage of Haemophilus influenzae in healthy Gambian children. (1989) (33)
Malaria in pregnancy in an area of stable and intense transmission: is it asymptomatic? (2008) (33)
Reduction in the mean number of Plasmodium falciparum genotypes in Gambian children immunized with the malaria vaccine SPf66. (1999) (33)
Public Health Impact After the Introduction of PsA-TT: The First 4 Years (2015) (33)
DECLINE IN SENSITIVITY OF PLASMODIUM FALCIPARUM TO CHLOROQUINE IN THE GAMBIA (1987) (33)
Effects of community‐wide use of lambdacyhalothrin‐impregnated bednets on malaria vectors in rural Sierra Leone (1997) (33)
Enhancement of the immune response to meningococcal polysaccharide vaccine in a malaria endemic area by administration of chloroquine (1981) (33)
Renal involvement in Gambian children with cerebral or mild malaria (1999) (33)
Safety and immunogenicity of pneumococcal conjugate vaccine in combination with diphtheria, tetanus toxoid, pertussis and Haemophilus influenzae type b conjugate vaccine (2002) (32)
Effect of fever on the serum antibody response of Gambian children to Haemophilus influenzae type b conjugate vaccine (2000) (32)
BED-NETS AND MALARIA SUPPRESSION (1987) (32)
Seroepidemiological and parasitological evaluation of the heterogeneity of malaria infection in the Gambia (2013) (32)
Safety and immunogenicity of Haemophilus influenzae type B-Neisseria meningitidis group B outer membrane protein complex conjugate vaccine mixed in the syringe with diphtheria-tetanus-pertussis vaccine in young Gambian infants. (1993) (32)
Comparison of all-cause and malaria-specific mortality from two West African countries with different malaria transmission patterns (2008) (32)
Safety and immunogenicity of the malaria candidate vaccines FP9 CS and MVA CS in adult Gambian men. (2006) (31)
A call to action for the new decade of vaccines (2011) (31)
Baseline data of parasite clearance in patients with falciparum malaria treated with an artemisinin derivative: an individual patient data meta-analysis (2015) (31)
In vitro rosetting, cytoadherence, and microagglutination properties of Plasmodium falciparum-infected erythrocytes from Gambian and Tanzanian patients. (1990) (31)
Conclusions from the WHO multicenter study of serious infections in young infants. The WHO Young Infants Study Group. (1999) (31)
Human immune recognition of recombinant proteins representing discrete domains of the Plasmodium falciparum gamete surface protein, Pfs230 (1995) (31)
Does woodsmoke protect against malaria? (1987) (31)
Prevalence of neutralizing antibody to respiratory syncytial virus in sera from mothers and newborns residing in the Gambia and in The United States (1996) (31)
Prolongation of the QTc interval in African children treated for falciparum malaria. (1997) (31)
The spectrum of hypoxaemia in children admitted to hospital in The Gambia, West Africa (2006) (31)
Adhesion of parasitized red blood cells to cultured endothelial cells: a flow-based study of isolates from Gambian children with falciparum malaria (1993) (31)
Protective Efficacy of Intermittent Preventive Treatment of Malaria in Infants (IPTi) Using Sulfadoxine-Pyrimethamine and Parasite Resistance (2010) (31)
Implementation of the malaria candidate vaccine RTS,S/AS01 (2016) (30)
What's new in malaria control? (1997) (30)
Acute lower respiratory infections in Gambian children: maternal perception of illness. (1990) (30)
Seasonal vaccination against malaria: a potential use for an imperfect malaria vaccine (2017) (30)
GROUP-C MENINGOCOCCAL MENINGITIS IN THE NORTHERN SAVANNA OF AFRICA (1975) (30)
Duration of Protection Against Clinical Malaria Provided by Three Regimens of Intermittent Preventive Treatment in Tanzanian Infants (2010) (30)
A review of the epidemiology and control of malaria in The Gambia, West Africa (1993) (30)
Comparison of the Prevalence of Common Bacterial Pathogens in the Oropharynx and Nasopharynx of Gambian Infants (2013) (30)
Seasonal Dynamics of Malaria in Pregnancy in West Africa: Evidence for Carriage of Infections Acquired Before Pregnancy Until First Contact with Antenatal Care (2017) (30)
Non-falciparum malaria infections in pregnant women in West Africa (2016) (29)
In‐vitro antibody‐dependent killing of schistosomula of Schistosoma haematobium by human eosinophils (1985) (29)
Financing mechanisms for village activities in The Gambia and their implications for financing insecticide for bednet impregnation. (1994) (29)
Antibody responses to Rhoptry‐Associated Protein‐1 (RAP‐1) of Plasmodium falciparum parasites in humans from areas of different malaria endemicity (1997) (29)
Predictors for a positive blood culture in African children with pneumonia. (1996) (29)
Can changes in malaria transmission intensity explain prolonged protection and contribute to high protective efficacy of intermittent preventive treatment for malaria in infants? (2008) (29)
Nasopharyngeal Carriage of Pneumococci Four Years after Community-Wide Vaccination with PCV-7 in The Gambia: Long-Term Evaluation of a Cluster Randomized Trial (2013) (29)
Use of a DNA hybridization assay for the detection of Plasmodium falciparum in field trials. (1987) (29)
Chlorproguanil-dapsone-artesunate versus chlorproguanil-dapsone: a randomized, double-blind, phase III trial in African children, adolescents, and adults with uncomplicated Plasmodium falciparum malaria. (2009) (29)
Bacteraemia in cerebral malaria. (1998) (29)
Health Centre Surveys as a Potential Tool for Monitoring Malaria Epidemiology by Area and over Time (2011) (29)
The impact of childhood vaccines on bacterial carriage in the nasopharynx: a longitudinal study (2015) (29)
The duration of the antibody response to meningococcal vaccination in an African village. (1980) (29)
Rheumatoid arthritis in three west African populations. (1972) (29)
Lessons from Italy (2006) (28)
Health & Demographic Surveillance System Profile: Farafenni Health and Demographic Surveillance System in The Gambia. (2015) (28)
EBOVAC-Salone: Lessons learned from implementing an Ebola vaccine trial in an Ebola-affected country (2018) (28)
Impact of intermittent preventive anti-malarial treatment on the growth and nutritional status of preschool children in rural Senegal (west Africa). (2007) (28)
Pneumococcal serotypes, epidemiological factors and vaccine strategy in Nigerian patients (1982) (28)
Suppression of in–vitro lymphoproliferative responses in acute malaria patients can be partially reversed by indomethacin (1989) (28)
Low-level malaria infections detected by a sensitive polymerase chain reaction assay and use of this technique in the evaluation of malaria vaccines in an endemic area. (2007) (28)
Household transmission of Neisseria meningitidis in the African meningitis belt: a longitudinal cohort study. (2016) (28)
Suppression of autoimmune disease in New Zealand mice associated with infection with malaria. I. (NZBxNZW) F1 hybrid mice. (1970) (28)
The complications of diabetes in Nigerians. (1968) (28)
Population genetic analysis of the Plasmodium falciparum erythrocyte binding antigen-175 (eba-175) gene. (2001) (27)
Safety of Seasonal Malaria Chemoprevention (SMC) with Sulfadoxine-Pyrimethamine plus Amodiaquine when Delivered to Children under 10 Years of Age by District Health Services in Senegal: Results from a Stepped-Wedge Cluster Randomized Trial (2016) (27)
Folic acid treatment of Zambian children with moderate to severe malaria anemia. (2006) (27)
Mechanisms of cytoadhesion of flowing, parasitized red blood cells from Gambian children with falciparum malaria. (1995) (27)
Methods for Identifying Neisseria meningitidis Carriers: A Multi-Center Study in the African Meningitis Belt (2013) (27)
Compliance with malaria chemoprophylaxis over a five-year period among children in a rural area of The Gambia. (1990) (27)
Human leucocyte antigen (HLA) and malaria morbidity in a Gambian community. (1993) (27)
The effects of antimalarials and folate supplements on haematological indices and red cell folate levels in Gambian children. (1988) (27)
Salivary antibody response to vaccination with meningococcal A/C polysaccharide vaccine in previously vaccinated and unvaccinated Gambian children. (2000) (27)
The efficacy of meningococcal polysaccharide vaccine in preventing group A meningococcal disease in The Gambia, West Africa. (1986) (26)
Progress in malaria control in endemic areas. (2008) (26)
Malaria Morbidity in Children in the Year after They Had Received Intermittent Preventive Treatment of Malaria in Mali: A Randomized Control Trial (2011) (26)
Preparation for a pneumococcal vaccine trial in The Gambia: individual or community randomisation? (1999) (26)
Ultrastructural analysis of fresh Plasmodium falciparum-infected erythrocytes and their cytoadherence to human leukocytes. (1992) (26)
A comparative study of Lapudrine (chlorproguanil) and Maloprim (pyrimethamine and dapsone) as chemoprophylactics against malaria in Gambian children. (1989) (26)
Causes of mortality in twins in a rural region of The Gambia, West Africa. (1998) (26)
The use of Haemophilus influenzae type b-tetanus toxoid conjugate vaccine mixed with diphtheria-tetanus-pertussis vaccine in Gambian infants. (1996) (26)
The Fever Trail: In Search of the Cure for Malaria (2002) (26)
The spirit of Dakar: a call for action on malaria (1997) (26)
The contribution of social science research to malaria prevention and control. (2002) (26)
Serologic responses to an Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer membrane protein conjugate vaccine in very young Gambian infants. (1990) (26)
Measuring cellular immune responses to malaria antigens in endemic populations: epidemiological, parasitological and physiological factors which influence in vitro assays. (1990) (26)
A randomised, double‐blind, placebo‐controlled trial of atovaquone–proguanil vs. sulphadoxine–pyrimethamine in the treatment of malarial anaemia in Zambian children (2006) (26)
Comparison of mortality between villages with and without Primary Health Care workers in Upper River Division, The Gambia. (1994) (26)
A pilot safety and immunogenicity study of the malaria vaccine SPf66 in Gambian infants (1995) (26)
Plasmodium falciparum schizont sonic extracts suppress lymphoproliferative responses to mitogens and antigens in malaria-immune adults (1989) (25)
Treponemal infection and the outcome of pregnancy in a rural area of The Gambia, west Africa. (1992) (25)
Making new vaccines affordable: a comparison of financing processes used to develop and deploy new meningococcal and pneumococcal conjugate vaccines (2011) (25)
Genomic characterization of novel Neisseria species (2019) (25)
Colostrum obtained from women vaccinated with pneumococcal vaccine during pregnancy inhibits epithelial adhesion of Streptococcus pneumoniae. (2004) (25)
Circulating ICAM-1 levels in falciparum malaria are high but unrelated to disease severity. (1996) (25)
A study of the role of immunological factors in the pathogenesis of the anaemia of acute malaria. (1978) (25)
The immune response to vaccination in undernourished and well-nourished Nigerian children. (1986) (25)
A prospective study of the influence of alpha thalassaemia on morbidity from malaria and immune responses to defined Plasmodium falciparum antigens in Gambian children. (1993) (25)
Child Mortality after Discharge from a Health Facility following Suspected Pneumonia, Meningitis or Septicaemia in Rural Gambia: A Cohort Study (2015) (24)
SEROLOGICAL COMPARISONS OF APPROACHES TO POLIO VACCINATION IN THE GAMBIA (1987) (24)
Childhood pneumonia and crowding, bed-sharing and nutrition: a case-control study from The Gambia (2016) (24)
Decreased Antitoxic Activities among Children with Clinical Episodes of Malaria (1998) (24)
Safety and Efficacy of Adding a Single Low Dose of Primaquine to the Treatment of Adult Patients With Plasmodium falciparum Malaria in Senegal, to Reduce Gametocyte Carriage: A Randomized Controlled Trial (2017) (24)
A randomized trial of chloramphenicol vs. trimethoprim‐sulfamethoxazole for the treatment of malnourished children with community‐acquired pneumonia (1995) (23)
Morbidity from Malaria in Children in the Year after They Had Received Intermittent Preventive Treatment of Malaria: A Randomised Trial (2011) (23)
The changing face of meningococcal disease in West Africa (2007) (23)
Sensitivity of Plasmodium falciparum in The Gambia to co-trimoxazole. (1991) (23)
Serious infections in young infants in developing countries: rationale for a multicenter study. The WHO Young Infants Study Group. (1999) (23)
A Phase II, Randomized Study on an Investigational DTPw-HBV/Hib-MenAC Conjugate Vaccine Administered to Infants in Northern Ghana (2008) (23)
Safety and long-term immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Sierra Leone: a combined open-label, non-randomised stage 1, and a randomised, double-blind, controlled stage 2 trial (2021) (23)
The Malumfashi project--an epidemiological, clinical and laboratory study. (1983) (23)
Persistence of antibodies to meningococcal IgA1 protease versus decay of antibodies to group A polysaccharide and Opc protein. (1997) (23)
The ecology and behaviour of the forest form of Anopheles gambiae s.s. (1993) (22)
Treatment of malaria--a continuing challenge. (2014) (22)
What can the residents of malaria endemic countries do to protect themselves against malaria? (1999) (22)
Cerebrospinal fluid immunoglobulins and complement in meningococcal meningitis. (1977) (22)
Coverage, Adherence and Costs of Intermittent Preventive Treatment of Malaria in Children Employing Different Delivery Strategies in Jasikan, Ghana (2011) (22)
Burkitt lymphoma and malaria. (1970) (22)
Coagulation studies in Gambian trypanosomiasis. (1976) (22)
A field trial of a single intramuscular injection of long-acting chloramphenicol in the treatment of meningococcal meningitis. (1984) (21)
Lack of inhibition of the anti-malarial action of sulfadoxine-pyrimethamine by folic acid supplementation when used for intermittent preventive treatment in Gambian primigravidae. (2006) (21)
The large contribution of twins to neonatal and post-neonatal mortality in The Gambia, a 5-year prospective study (2016) (21)
Epidemiology of rotavirus in a periurban Gambian community. (1987) (21)
Identification of host–pathogen-disease relationships using a scalable multiplex serology platform in UK Biobank (2019) (21)
Suppression of autoimmune disease in New Zealand mice associated with infection with malaria. II. NZB mice. (1970) (21)
Host-mediated selection impacts the diversity of Plasmodium falciparum antigens within infections (2018) (21)
Injectable anti-malarials revisited: discovery and development of new agents to protect against malaria (2018) (21)
Optimal dosing of dihydroartemisinin-piperaquine for seasonal malaria chemoprevention in young children (2019) (21)
Malaria in Middle Childhood and Adolescence (2017) (21)
C‐reactive protein and procalcitonin in the evaluation of the efficacy of a pneumococcal conjugate vaccine in Gambian children (2008) (21)
Soluble pIasma IL‐2 receptors and maIaria (1993) (21)
Combining community case management and intermittent preventive treatment for malaria. (2011) (21)
An ELISA test for detecting chloroquine in urine. (1988) (21)
Longitudinal estimation of Plasmodium falciparum prevalence in relation to malaria prevention measures in six sub-Saharan African countries (2017) (20)
Sustained use of insecticide-treated curtains is not associated with greater circulation of drug-resistant malaria parasites, or with higher risk of treatment failure among children with uncomplicated malaria in Burkina Faso. (2007) (20)
The safety of amodiaquine use in pregnant women (2007) (20)
Epidemiology of malaria among pregnant women during their first antenatal clinic visit in the middle belt of Ghana: a cross sectional study (2020) (20)
Hepatitis B vaccine in the Expanded Programme of Immunisation: the Gambian experience. (1989) (20)
Intermittent Preventive Treatment of Malaria in Children: A Qualitative Study of Community Perceptions and Recommendations in Burkina Faso and Mali (2012) (20)
Isolation of maternal mononuclear cells from placentas for use in in vitro functional assays. (1992) (20)
Early clinical failures after pyrimethamine-sulfadoxine treatment of uncomplicated falciparum malaria. (1996) (20)
Practice in Developing Countries (1990) (20)
Pneumococcal meningitis epidemics in Africa. (2006) (20)
Differential antibody response of Gambian donors to soluble Plasmodium falciparum antigens. (1991) (20)
An efficacy trial of the malaria vaccine SPf66 in Gambian infants--second year of follow-up. (1998) (20)
100 years of epidemic meningitis in West Africa - has anything changed? [editorial] (2006) (19)
Modelling the Protective Efficacy of Alternative Delivery Schedules for Intermittent Preventive Treatment of Malaria in Infants and Children (2011) (19)
Seasonality of Pneumococcal Nasopharyngeal Carriage in Rural Gambia Determined within the Context of a Cluster Randomized Pneumococcal Vaccine Trial (2015) (19)
Transthoracic lung aspiration for the aetiological diagnosis of pneumonia: 25 years of experience from The Gambia. (2011) (19)
A national survey of the prevalence of chloroquine resistant Plasmodium falciparum malaria in The Gambia. (1990) (19)
Iron-deficiency anaemia and its response to oral iron: report of a study in rural Gambian children treated at home by their mothers. (1989) (19)
Influences of Intermittent Preventive Treatment and Persistent Multiclonal Plasmodium falciparum Infections on Clinical Malaria Risk (2010) (19)
Alternative Molecular Methods for Improved Detection of Meningococcal Carriage and Measurement of Bacterial Density (2016) (19)
New tools for malaria control - using them wisely. (2017) (18)
Implementing a nationwide insecticide-impregnated bednet programme in The Gambia. (1996) (18)
Malaria vaccine trials in pregnant women: An imperative without precedent. (2019) (18)
Amodiaquine Dosage and Tolerability for Intermittent Preventive Treatment To Prevent Malaria in Children (2010) (18)
Soluble products of inflammatory reactions are not induced in children with asymptomatic Plasmodium falciparum infections (1996) (18)
A SUPPRESSOR T-CELL DEFECT IN TROPICAL SPLENOMEGALY SYNDROME (1976) (18)
Interpreting vaccine efficacy. (2005) (18)
How best to treat bed nets with insecticide in the field. (1988) (17)
Lymphocytic infiltration of the brain in sleeping sickness. (1976) (17)
Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in children in Sierra Leone: a randomised, double-blind, controlled trial (2021) (17)
PROGNOSTIC VALUE OF CSF LACTATE IN CEREBRAL MALARIA (1987) (17)
Evaluating Health Workers' Potential Resistance to New Interventions: A Role for Discrete Choice Experiments (2011) (17)
Immune responses to sporozoite antigens and their relationship to naturally acquired immunity to malaria. (1990) (17)
An epidemic of meningococcal infection at Zaria, Northern Nigeria. 2. The changing clinical pattern. (1979) (17)
Meningococcal carriage within households in the African meningitis belt: A longitudinal pilot study (2017) (17)
Populations at risk. (1990) (17)
Diurnal variation in body temperature of Gambian children. (1994) (17)
Seroprevalence of antibodies to group B streptococcal polysaccharides in Gambian mothers and their newborns. (1998) (16)
A Historical Review of WHO Certification of Malaria Elimination. (2019) (16)
The risk of malaria in Ghanaian infants born to women managed in pregnancy with intermittent screening and treatment for malaria or intermittent preventive treatment with sulfadoxine/pyrimethamine (2016) (16)
Suppression of adjuvant arthritis by infection with a strain of the rodent malaria parasite Plasmodium berghei. (1970) (16)
Diversion of Anopheles gambiae from children to other hosts following exposure to permethrin‐treated bednets (2000) (16)
Malaria and haemoglobin genotype in young northern Nigerian children. (1985) (16)
A polymerase chain reaction for the diagnosis of Haemophilus influenzae type b disease in children and its evaluation during a vaccine trial. (1998) (16)
Chemotactic activity of cerebrospinal fluid in pyogenic meningitis. (1978) (16)
Zinc as an adjunct therapy in the management of severe pneumonia among Gambian children: randomized controlled trial (2018) (16)
Sporozoite antibodies and malaria in children in a rural area of The Gambia. (1989) (16)
Immunological aspects of nephrotic syndrome in northern Nigeria. (1981) (16)
Detecting permethrin on treated bed nets (1994) (16)
Primary liver cell carcinoma (PLCC) in the Northern Guinea Savanna of Nigeria. (1977) (16)
Increased Disease due to Haemophilus influenzae Type b: Population-based Surveillance in Eastern Gambia, 2008–2013 (2015) (16)
Immunogenicity of pneumococcal conjugate vaccine formulations containing pneumococcal proteins, and immunogenicity and reactogenicity of co-administered routine vaccines - A phase II, randomised, observer-blind study in Gambian infants. (2019) (16)
Comparison of the therapeutic efficacy of chloroquine and sulphadoxine‐pyremethamine in children and pregnant women (2007) (16)
Low Incidence of Rheumatoid Factor and Autoantibodies in Nigerian Patients with Rheumatoid Arthritis (1970) (16)
Cellular and humoral inhibition of Plasmodium falciparum growth in vitro and recovery from acute malaria (1985) (15)
Malaria chemoprophylaxis in endemic regions. (1991) (15)
The cost-effectiveness of chemoprophylaxis with Maloprim administered by primary health care workers in preventing death from malaria amongst rural Gambian children aged less than five years old. (1992) (15)
Malaria control in Africa: progress but still much to do (2014) (15)
Meningococcal Meningitis in the Northern Savanna of Africa (1976) (15)
Pulmonary lesions in African histoplasmosis. (1968) (15)
The Gates Malaria Partnership: a consortium approach to malaria research and capacity development (2012) (15)
Lack of an association between acute gastroenteritis, acute respiratory infections and malaria in young Gambian children. (1989) (15)
Prevention of the Recurrence of Anaemia in Gambian Children Following Discharge from Hospital (2010) (15)
Antigen-negative meningitis due to group A Neisseria meningitidis. (1974) (15)
New and resurgent infections: prediction detection and management of tomorrows epidemics. (1998) (15)
Intermittent preventive treatment for malaria in infants: a decision-support tool for sub-Saharan Africa. (2010) (15)
Tuberculin sensitivity in rural Gambian children. (1985) (14)
Mitogenic activity of an extract of Trypanosoma gambiense. (1978) (14)
The need for targeted implementation research to improve coverage of basic vaccines and introduction of new vaccines. (2013) (14)
Cost effectiveness of intermittent screening followed by treatment versus intermittent preventive treatment during pregnancy in West Africa: analysis and modelling of results from a non-inferiority trial (2016) (14)
Seroreactivity with the Plasmodium falciparum blood stage antigen Pf332 in adults and children from malaria‐endemic regions (1993) (14)
Children in Burkina Faso who are protected by insecticide-treated materials are able to clear drug-resistant parasites better than unprotected children. (2007) (14)
Malaria-attributed death rates in India (2011) (14)
DNA fingerprinting in the epidemiology of African serogroup A Neisseria meningitidis. (1992) (14)
Immunological consequences of intermittent preventive treatment against malaria in Senegalese preschool children (2010) (14)
Plasmodium falciparum gametocytes in Gambian adults (2000) (13)
Evaluation of seasonal malaria chemoprevention in two areas of intense seasonal malaria transmission: Secondary analysis of a household-randomised, placebo-controlled trial in Houndé District, Burkina Faso and Bougouni District, Mali (2020) (13)
Disease-specific mortality burdens in a rural Gambian population using verbal autopsy, 1998–2007 (2014) (13)
Entomological characteristics of the study area (1993) (13)
The immunogenicity and safety of Haemophilus influenzae type b-tetanus toxoid conjugate vaccine in Gambian infants. (1994) (13)
A record system for drug administration by illiterate village health workers. (1987) (13)
Polyarthritis in Western Nigeria. 3. Other forms of polyarthritis. (1970) (13)
Immune complexes and the pathogenesis of meningococcal arthritis. (1985) (13)
A health facility based case–control study of effectiveness of insecticide treated nets: potential for selection bias due to pre‐treatment with chloroquine (2003) (13)
Susceptibility of Plasmodium falciparum in The Gambia to pyrimethamine, Maloprim and chloroquine. (1985) (13)
Fibrin degradation products in the serum and cerebrospinal fluid of patients with group A meningococcal meningitis (1974) (13)
Evidence for familial immune defect in meningococcal meningitis. (1976) (13)
Failure of heparin to alter the outcome of pneumococcal meningitis. (1977) (13)
Revaccination with Bacillus Calmette‐Guerin (BCG) vaccine does not reduce morbidity from malaria in African children (2006) (13)
Cryoglobulinaemia and circulating immune complexes in tropical splenomegaly syndrome. (1978) (13)
ELISA tests for dapsone and pyrimethamine and their application in a malaria chemoprophylaxis programme. (1986) (13)
A Randomized Trial to Compare the Safety, Tolerability, and Effectiveness of 3 Antimalarial Regimens for the Prevention of Malaria in Nigerian Patients With Sickle Cell Disease (2015) (12)
Factors associated with severe anaemia in Zambian children admitted with Plasmodium falciparum malarial anaemia (2005) (12)
Hierarchical genomic analysis of carried and invasive serogroup A Neisseria meningitidis during the 2011 epidemic in Chad (2017) (12)
Malaria in the Post-Genome Era (2012) (12)
Narrative review of methods and findings of recent studies on the carriage of meningococci and other Neisseria species in the African Meningitis Belt (2018) (12)
Immunological correlates of protection for the RTS,S candidate malaria vaccine. (2011) (12)
An evaluation of the immunogenicity and safety of a new trivalent meningococcal polysaccharide vaccine. (2007) (12)
Risk factors for acquisition of meningococcal carriage in the African meningitis belt (2019) (12)
Capacity strengthening in malaria research: the Gates Malaria Partnership. (2006) (12)
The epidemiology of malaria in southern Sierra Leone. (1993) (12)
Follow‐up of Gambian children recruited to a pilot safety and immunogenicity study of the malaria vaccine SPf66 (1997) (12)
Efficacy of two artemisinin-based combinations for the treatment of malaria in pregnancy in India: a randomized controlled trial (2018) (12)
MENINGOCOCCAL BACTERAEMIA IN FEBRILE CONTACTS OF PATIENTS WITH MENINGOCOCCAL DISEASE (1986) (12)
Risk factors for acquisition of meningococcal carriage in the African meningitis belt (2019) (12)
Malaria vaccine trials. (2002) (12)
Normal immunoglobulins in the tropics. (1973) (12)
Haptoglobin genotypes are not associated with resistance to severe malaria in The Gambia. (2002) (11)
T- and B-lymphocyte subpopulations in the tropical splenomegaly syndrome (TSS). (1978) (11)
Efficacy of different pneumococcal conjugate vaccine schedules against pneumonia, hospitalisation, and mortality: re-analysis of a randomised trial in the Gambia. (2014) (11)
Measurement of serum haptoglobin as an indicator of the efficacy of malaria intervention trials. (1992) (11)
Childhood pneumonia--preventing the worlds biggest killer of children. (2007) (11)
Fever and malaria (1996) (11)
Erratum: Effect of removing direct payment for health care on utilisation and health outcomes in Ghanaian children: A randomised controlled trial (PLoS medicine (2009) 6:2 (e1000033)DOI:10.1371/journal.pmed.1000007)). (2009) (11)
Optimization of a rapid nonisotopic DNA probe assay for Plasmodium falciparum in the Gambia (1991) (11)
Proactive case detection of common childhood illnesses by community health workers: a systematic review (2019) (11)
Cellular immunity in patients with meningococcal disease and in vaccinated subjects. (1979) (11)
Polyarthritis in Western Nigeria. II. Still's disease. (1969) (11)
Modern vaccines. Practice in developing countries. (1990) (11)
Analysis of partial and complete protection in malaria cohort studies (2013) (11)
Mode of action and choice of antimalarial drugs for intermittent preventive treatment in infants. (2009) (11)
The impact of malaria chemoprophylaxis on the immune status of Africans. (1984) (11)
Riboflavin, folate and vitamin C status of Gambian women during pregnancy: a comparison between urban and rural communities. (1987) (11)
Tropical splenomegaly syndrome or chronic lymphatic leukaemia? (1979) (11)
The mysteries of immunity to malaria (2011) (10)
Coincidence of malaria parasitaemia and abnormal chest X-ray findings in young Gambian children. (1991) (10)
Persistence of antibody at 18 months following vaccination of young Gambian infants with PRP-OMPC Haemophilus influenzae type b conjugate vaccine. (1993) (10)
Higher Tetanus Toxoid Immunity 2 Years After PsA-TT Introduction in Mali (2015) (10)
Impact of the introduction of pneumococcal conjugate vaccination on invasive pneumococcal disease and pneumonia in The Gambia: 10 years of population-based surveillance (2021) (10)
From genomics to surveillance, prevention and control: new challenges for the African meningitis belt. (2006) (10)
Screening for a raised rectal temperature in Africa. (1993) (10)
Metabolism of IgM in the tropical splenomegaly syndrome. (1976) (10)
Seasonal malaria vaccination: protocol of a phase 3 trial of seasonal vaccination with the RTS,S/AS01E vaccine, seasonal malaria chemoprevention and the combination of vaccination and chemoprevention (2020) (10)
Sensitivity of Plasmodium falciparum to Maloprim after five years of targetted chemoprophylaxis in a rural area of The Gambia. (1990) (10)
Antibiotic susceptibility of invasive and non-invasive isolates of Haemophilus influenzae from the Gambia, west Africa. (1994) (10)
Absence of crisis form factor in subjects immune to Plasmodium falciparum in The Gambia, West Africa. (1987) (10)
The effect of distance on observed mortality, childhood pneumonia and vaccine efficacy in rural Gambia (2014) (10)
Guinea-worm Arthritis of Knee Joint (1968) (10)
Development of a PCR algorithm to detect and characterize Neisseria meningitidis carriage isolates in the African meningitis belt (2018) (10)
Molecular epidemiology of Haemophilus influenzae type b in the Gambia (1992) (10)
CHLOROQUINE PROPHYLAXIS AND ANTIBODY RESPONSE TO IMMUNISATION (1984) (10)
Acute tropical polyarthritis. (1969) (10)
Association of the TNF-238 promoter polymorphism with susceptibility to tuberculosis and malaria in Africa (1996) (10)
Clinical presentations and management of COVID-19 infected children seen in a district health facility in Kambia, northern Sierra Leone (2020) (10)
Systemic Iupus erytmatous in African immigrant (2001) (9)
Evaluation of benzothiocarboxypurine for malaria diagnosis in an endemic area. (1993) (9)
Heterophile antibodies in Nigerian sera. (1970) (9)
Malaria and bacteraemia in African children (2011) (9)
Non-malaria fevers in a high malaria endemic area of Ghana (2016) (9)
Malaria and helminth co-infections in children living in endemic countries: A systematic review with meta-analysis (2021) (9)
Systemic lupus erythematosus in African immigrants. (2001) (9)
Clinical experience with enteric fever in The Gambia, West Africa 1981-1986. (1989) (9)
What can be expected from malaria vaccines (1997) (9)
Measles antibody levels from birth to 9 months of age in Nigerian infants. (1982) (9)
Malaria vaccination and rebound malaria. (2019) (9)
Temporal changes in nasopharyngeal carriage of Streptococcus pneumoniae serotype 1 genotypes in healthy Gambians before and after the 7-valent pneumococcal conjugate vaccine (2015) (9)
Nature of the antigen present in the cerebrospinal fluid and serum of patients with group A meningococcal meningitis. (1974) (9)
A randomised trial of a Haemophilus influenzae type b conjugate vaccine in a developing country for the prevention of pneumonia--ethical considerations. (1999) (9)
Molecular approaches to malaria and babesiosis diagnosis. (1992) (9)
Staphylococcus aureus Bacteremia in Children of Rural Areas of The Gambia, 2008–2015 (2019) (8)
Hyperpigmented dermal macules in children following the administration of Maloprim for malaria chemoprophylaxis. (1997) (8)
Prevalence and risk factors for Staphylococcus aureus nasopharyngeal carriage during a PCV trial (2017) (8)
HLA, malaria and dominant protective associations. (1992) (8)
Hepatitis--B antigen in Nigerian children. (1973) (8)
Immune complexes in Gambian sleeping sickness. (1980) (8)
A double comparative study of the acceptability of untreated bed nets versus permethrin, lambda-cyhalothrin and deltamethrin impregnated bed nets. (1994) (8)
A comparison of chloroquine and pyrimethamine as malaria chemoprophylactics in young Nigerian children. (1985) (8)
Low molecular weight (7S) IgM and free light chains in the sera of patients with the tropical splenomegaly syndrome. (1977) (8)
Epitopes of the Plasmodium falciparum clustered‐asparagine‐rich protein (CARP) recognized by human T‐cells and antibodies (1991) (8)
The contribution of Gambian traditional birth attendants to field research. (1993) (8)
The influence of malaria on plasma retinol (1990) (8)
Bench aids for the diagnosis of malaria infections 2nd edition (2001) (8)
Production of free light chains in Gambian trypanosomiasis (1975) (8)
Is there a genetic immune defect in families with meningococcal meningitis? (1981) (7)
Simulation-guided phase 3 trial design to evaluate vaccine effectiveness to prevent Ebola virus disease infection: Statistical considerations, design rationale, and challenges (2016) (7)
Pneumococcal Antibody Concentrations and Carriage of Pneumococci more than 3 Years after Infant Immunization with a Pneumococcal Conjugate Vaccine (2012) (7)
Combining malaria vaccination with chemoprevention: a promising new approach to malaria control (2021) (7)
Disease-specific mortality burdens in a rural Gambian population using verbal autopsy, 1998-2007. (2014) (7)
Biochemical and haematological variables in Gambian children with cerebral malaria. (1999) (7)
Elimination of malaria: halfway there. (2017) (7)
Competing risk events in antimalarial drug trials in uncomplicated Plasmodium falciparum malaria: a WorldWide Antimalarial Resistance Network individual participant data meta-analysis (2019) (7)
The Duration of Protection from Azithromycin Against Malaria, Acute Respiratory, Gastrointestinal, and Skin Infections When Given Alongside Seasonal Malaria Chemoprevention: Secondary Analyses of Data from a Clinical Trial in Houndé, Burkina Faso, and Bougouni, Mali (2021) (7)
Progress with the PfSPZ Vaccine for malaria. (2017) (7)
Analysis of Preventive Interventions for Malaria: Exploring Partial and Complete Protection and Total and Primary Intervention Effects (2015) (7)
Capillary Resistance and Skin-Fold Thickness in Patients with Rheumatoid Arthritis (1966) (7)
Intermittent screening and treatment with artemisinin-combination therapy versus intermittent preventive treatment with sulphadoxine-pyrimethamine for malaria in pregnancy: a systematic review and individual participant data meta-analysis of randomised clinical trials (2021) (7)
BACTERIOLOGICAL FINDINGS IN PNEUMONIA (1974) (7)
Nasopharyngeal colonization of Gambian infants by Staphylococcus aureus and Streptococcus pneumoniae before the introduction of pneumococcal conjugate vaccines (2015) (7)
Bacterial Meningitis 3 Eff ect of vaccines on bacterial meningitis worldwide (2012) (7)
Guinea worm infection in northern Nigeria: reflections on a disease approaching eradication (2017) (7)
Antibody reactivities to glutamate‐rich peptides of Plasmodium falciparum parasites in humans from areas of different malaria endemicity (1996) (7)
In vitro sensitivity of Plasmodium falciparum to chlorcycloguanil in The Gambia. (1985) (7)
Partnership for Research on Ebola VACcination (PREVAC): protocol of a randomized, double-blind, placebo-controlled phase 2 clinical trial evaluating three vaccine strategies against Ebola in healthy volunteers in four West African countries (2020) (6)
Sensitivity of Plasmodium falciparum to chlorproguanil in Gambian children after five years of continuous chemoprophylaxis. (1990) (6)
Mortality in tropical splenomegaly syndrome. (1980) (6)
Useofsimple clinical signstopredict pneumonia inyoungGambianchildren: theinfluence ofmalnutrition (1995) (6)
Malaria--first, roll back expectations. (2000) (6)
Humoral immune responses in Gambians to Pfs16, an immunodominant, Plasmodium falciparum integral membrane protein (1996) (6)
Effectiveness of intermittent screening and treatment for the control of malaria in pregnancy: a cluster randomised trial in India (2019) (6)
Leishmaniasis in The Gambia. 3. Is its incidence increasing? (1984) (6)
Impact of the addition of azithromycin to antimalarials used for seasonal malaria chemoprevention on antimicrobial resistance of Streptococcus pneumoniae (2019) (6)
A Seroepidemiological Study of Serogroup A Meningococcal Infection in the African Meningitis Belt (2016) (6)
Investigation of correlates of protection against pharyngeal carriage of Neisseria meningitidis genogroups W and Y in the African meningitis belt (2017) (6)
Partnership for Research on Ebola VACcination (PREVAC): protocol of a randomized, double-blind, placebo-controlled phase 2 clinical trial evaluating three vaccine strategies against Ebola in healthy volunteers in four West African countries (2020) (6)
Transthoracic lung aspiration for the aetiological diagnosis of pneumonia: 25 years of experience from The Gambia [Review article]. (2011) (6)
Design and implementation of the trial (1993) (6)
A seriological investigation of Q fever in clinical patients. (1977) (5)
Meningococcal infection and proteolytic control. (1978) (5)
Can we defeat meningococcal disease in low and middle income countries? (2012) (5)
Sequential bacteriological findings in the cerebrospinal fluid of Nigerian patients with pneumococcal meningitis. (1986) (5)
Effectiveness of intermittent preventive treatment in pregnancy with sulphadoxine-pyrimethamine (IPTp-SP) in Ghana (2021) (5)
Primaquine to stop transmission of falciparum malaria. (2016) (5)
Implementing a novel community engagement system during a clinical trial of a candidate Ebola vaccine within an outbreak setting (2016) (5)
A comparison of two DNA probes, one specific for Plasmodium falciparum and one with wider reactivity, in the diagnosis of malaria. (1990) (5)
Fibrin degradation products in the cerebrospinal fluid of patients with pneumococcal meningitis. (1979) (5)
A cluster-randomised, non-inferiority trial of the impact of a two-dose compared to three-dose schedule of pneumococcal conjugate vaccination in rural Gambia: the PVS trial (2022) (5)
Microcomputer management of a vaccine trial. (1988) (5)
The abolition of infection: hope or illusion? (1983) (5)
Opportunities and challenges for pneumococcal conjugate vaccines in low- and middle-income countries. (2008) (5)
Treating malaria in Africa (2004) (5)
The nature of hepatic lymphocytic infiltrates in the tropical splenomegaly syndrome. (1982) (5)
Nutritional status of children admitted to hospital with different diseases and its relationship to outcome in The Gambia, West AfricaA systematic approach to the development of a rational malaria treatment policy in Zambia (1998) (5)
The role of malaria in childhood nephrotic syndrome in northern Nigeria. (1983) (5)
Respiratory rate as a predictor of positive lung aspirates in young Gambian children with lobar pneumonia (2001) (5)
Meningococcal carriage among Hajj pilgrims, risk factors for carriage and records of vaccination: a study of pilgrims to Mecca (2021) (5)
AUTOIMMUNE DISEASE IN NIGERIANS (1968) (5)
After a trial is over: the ethical issues (2003) (5)
Supporting capacity for research on malaria in Africa (2018) (5)
Kinetics of antibodies against pneumococcal proteins and their relationship to nasopharyngeal carriage in the first two months of life (2017) (4)
Measurement of growth-inhibiting (bactericidal) antibodies in patients with meningococcal meningitis and in subjects immunized with meningococcal polysaccharide vaccine by a [3H]thymidine assay (1985) (4)
Defeating meningitis by 2030 – an ambitious target (2021) (4)
A new approach to the definition of seroconversion following vaccination in a population with high background antibody concentrations. (2007) (4)
POLYARTHRITIS IN WESTERN NIGERIA . II (4)
Controlled trial of lambda-cyhalothrin impregnated bed nets and Maloprim chemosuppression to control malaria in children living in a holoendemic area of Sierra Leone, west Africa. Study design and preliminary results. (1993) (4)
Antigenuria in Gambian infants following immunization with a Haemophilus influenzae type b polyribosylribitol phosphate-tetanus toxoid protein conjugate (PRP-T) vaccine. (1998) (4)
Pneumococcal Antibody Concentrations of Subjects in Communities Fully or Partially Vaccinated with a Seven-Valent Pneumococcal Conjugate Vaccine (2012) (4)
New Decade of Vaccines 4 The future of immunisation policy , implementation , and fi nancing (2011) (4)
The immunology of malaria—a view from the bush (1985) (4)
An evaluation of the Widal test in the diagnosis of enteric fever. (1989) (4)
The bacteriological diagnosis of pyogenic meningitis from cerebrospinal fluid dried on filter paper. (1976) (4)
Malaria infection in adult NZB mice and in adult (NZB x NZW) F 1 hybrid mice. (1971) (4)
Hypocomplementaemia in children with Plasmodium falciparum malaria. (1978) (4)
Correction: Safety of Seasonal Malaria Chemoprevention (SMC) with Sulfadoxine-Pyrimethamine plus Amodiaquine when Delivered to Children under 10 Years of Age by District Health Services in Senegal: Results from a Stepped-Wedge Cluster Randomized Trial (2016) (4)
Response to pneumococcal vaccination in normal and post-infected Nigerians. (1985) (4)
Heterologous prime-boost immunisation in Ebola vaccine development , testing and licensure (2015) (4)
Sickle cell trait and the immune response to meningococcal vaccines. (1981) (4)
Relationship between malaria endemicity and acute febrile illness mortality in children. (2001) (4)
A clonal analysis of Neisseria meningitidis serogroup A (2004) (4)
Haemophilus Influenzae type b meningitis after three doses of vaccine (1994) (4)
KAPOSI'S SARCOMA IN ZAMBIA (1984) (3)
AIDS AND STUDENT ELECTIVES OVERSEAS (1987) (3)
Corticosteroids for acute bacterial meningitis. (2007) (3)
Randomized Trial of Vaccines for Zaire Ebola Virus Disease. (2022) (3)
The use of a placebo in vaccine trials (2014) (3)
Data Management for an Efficacy Trial of a Vaccine in the Gambia (1997) (3)
Injectable anti-malarials revisited: discovery and development of new agents to protect against malaria (2018) (3)
A cerebrospinal fluid leucocidin in pyogenic meningitis. (1978) (3)
Autoimmune diseases in Nigerians. (1968) (3)
Ulcerative Colitis in Africans (1966) (3)
A vaccine to prevent epidemic meningitis in Africa. (2012) (3)
Prevention of Malaria in Pregnancy (2018) (3)
Persistent and emerging pneumococcal carriage serotypes in a rural Gambian community after ten years of pneumococcal conjugate vaccine pressure. (2020) (3)
Treatment and Prevention of Meningococcal Disease (1984) (3)
Antiglobulins in Nigerians with rheumatoid disease. (1975) (3)
Healthcare Seeking and Access to Care for Pneumonia, Sepsis, Meningitis, and Malaria in Rural Gambia (2021) (3)
Randomized non-inferiority trial of dihydroartemisinin-piperaquine compared with sulfadoxine- 1 pyrimethamine plus amodiaquine for SMC in Burkina Faso (2015) (3)
DOES CHLOROQUINE CAUSE HYPOGLYCAEMIA IN THE ABSENCE OF CLINICAL MALARIA? (1987) (3)
Treatment of acute meningococcaemia with chemotherapy and immune plasma. (1980) (3)
4 – ETHICS AND VACCINES (2003) (3)
Erratum: Heterozygote advantage for HLA class-II type in hepatitis B virus infection (Nature Genetics (1997) 17 (10-11)) (1998) (2)
Intermittent preventive treatment of malaria decreases the anti- Plasmodium schizont antibody response of Senegalese children (2009) (2)
Are insecticide treated bednets failing? (2012) (2)
Phase Ii, Randomized Trial to Assess the Safety and Immunogenicity of the Candidate Malaria Vaccines Rts,S/As02 and Rts,S/As01 When Given According to Different Vaccination Schedules in Children in Ghana (2008) (2)
A comparative study of parenteral chloroquine, quinine and pyrimethamine-sulfadoxine in the treatment of Gambian children with complicated, non-cerebral malaria. (1996) (2)
Effect of adding azithromycin to the antimalarials used for seasonal malaria chemoprevention on the nutritional status of African children (2020) (2)
Chlorproguanil-Dapsone-Artesunate Vs. Chlorproguanil-Dapsone: A Randomised, Double-Blind Phase Iii Trial for the Treatment of Acute Uncomplicated Plasmodium Falciparum Malaria (2008) (2)
Chlorproguanil 2 Dapsone 2 Artesunate versus Artemether 2 Lumefantrine : A Randomized , Double-Blind Phase III Trial in African Children and Adolescents with Uncomplicated Plasmodium falciparum Malaria (2009) (2)
Nutritional status in young children prior to the malaria transmission season in Burkina Faso and Mali, and its impact on the incidence of clinical malaria (2021) (2)
Malaria: the role of agriculture in changing the epidemiology of malaria. (1998) (2)
Amoebiasis in northern Nigeria. An evaluation of the gel diffusion test. (1978) (2)
Population-based surveillance for pneumonia, sepsis and meningitis in all ages in The Gambia: Implications for pneumococcal vaccine introduction and surveillance in Africa (2010) (2)
Alpha-fetoprotein and amoebic liver abscess. (Letter) (1976) (2)
Seasonal use case for the RTS,S/AS01 malaria vaccine: a mathematical modelling study. (2022) (2)
Prevalence and distribution pattern of malaria and soil-transmitted helminth co-endemicity in sub-Saharan Africa, 2000–2018: A geospatial analysis (2022) (2)
Chlorproguanil-Dapsone-Artesu Nate Vs. Artemether-Lumefantrine: A Randomised, Double-Blind Phase Iii Trial for the Treatment of Acute, Uncomplicated Plasmodium Falciparum Malaria in African Children and Adolescents (2008) (2)
Seroepidemiological and parasitological evaluation of the heterogeneity of malaria infection in the Gambia (2013) (2)
Challenges and lessons learned during the planning and early implementation of the RTS,S/AS01E malaria vaccine in three regions of Ghana: a qualitative study (2022) (2)
Malaria policy advisory committee to the WHO: conclusions and recommendations of fifth biannual meeting (March 2014) (2014) (2)
Traditional medicine to DNA vaccines: the advance of medical research in West Africa (1998) (2)
The accuracy of the clinical histories given by mothers of sick African children. (1987) (2)
The Anti-Circumsporozoite Antibody Response of Children to Seasonal Vaccination With the RTS,S/AS01E Malaria Vaccine (2021) (2)
Studies with combined meningococcal vaccines: I. A combined meningococcal, measles and tetanus vaccine (1981) (2)
Refugees: towards better access to health-care services (2016) (2)
Response to Buffet et al: Intermittent preventive anti-malarial treatment to children (IPTc): firebreak or fire trap? (2008) (2)
DISSEMINATED INTRAVASCULAR COAGULATION CAUSED BY CARPET VIPER (ECHIS CARINATUS) (1975) (2)
Erratum: Heterozygote advantage for HLA class-II type in hepatitis B virus infection (1998) (2)
Safety and immunogenicity of an Ad26.ZEBOV booster dose in children previously vaccinated with the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen: an open-label, non-randomised, phase 2 trial. (2022) (2)
Letter: Alpha-fetoprotein and amoebic liver abscess. (1976) (2)
Resurgent and delayed malaria (2022) (2)
Correction: A Seroepidemiological Study of Serogroup A Meningococcal Infection in the African Meningitis Belt (2016) (2)
Haematological consequences of acute uncomplicated falciparum malaria: a WorldWide Antimalarial Resistance Network pooled analysis of individual patient data (2022) (2)
Season and miningococcal disease in northern Nigeria (1983) (2)
MENINGOCOCCAL VACCINE: INTRADERMAL VERSUS SUBCUTANEOUS (1984) (2)
Maternal immunisation in developing countries. Review. (2003) (1)
Global health and the Bill & Melinda Gates Foundation (2009) (1)
Evaluation of Implementation of Intermittent Screening and Treatment for Control of Malaria in Pregnancy in Jharkhand, India (2020) (1)
Practical aspects of phase 3 vaccine trials in developing countries (2005) (1)
Correction: Manslaughter by Fake Artesunate in Asia—Will Africa Be Next? (2006) (1)
Sustaining Protection Against Epidemic Meningitis in Africa After Vaccination. (2018) (1)
Inhibitory effect of cerebrospinal fluid on the growth of meningococci and pneumococci. (1984) (1)
Royal Society of Tropical Medicine and Hygiene: 100 years old (2007) (1)
Acute intermittent porphyria in Nigerians. (1967) (1)
PRIMARY LIVER-CELL CARCINOMA IN THE SAVANNAH COUNTRY OF NORTHERN NIGERIA (1976) (1)
Risk factors for severe malaria: importance of careful study design. (1999) (1)
Cerebral malaria (1991) (1)
The impact of the COVID-19 pandemic on the provision & utilisation of primary health care services in Goma, Democratic Republic of the Congo, Kambia district, Sierra Leone & Masaka district, Uganda (2022) (1)
Malaria chemoprophylaxis in the Gambia. Comparison of two strategies for control of malaria within a primary health care programme in the Gambia. (1989) (1)
How much more malaria could be prevented? (2016) (1)
Temporal distribution of Plasmodium falciparum recrudescence following artemisinin-based combination therapy: an individual participant data meta-analysis (2022) (1)
Inﬂuence of malaria transmission intensity and the 581G mutation on the efﬁcacy of intermittent preventive treatment in pregnancy: systematic review and meta-analysis (2018) (1)
SDS-PAGE analysis of membrane proteins of group A Neisseria meningitidis isolated before and during an epidemic of group A meningococcal disease in northern Nigeria. (1987) (1)
Mefloquine safety and tolerability in pregnancy: a systematic literature review (2014) (1)
Chemoprevention for the Populations of Malaria Endemic Africa (2022) (1)
Country Data for Action: The MenAfriNet Experience in Strengthening Meningitis Surveillance in Africa. (2019) (1)
Non-falciparum malaria infections in pregnant women in West Africa (2016) (1)
Pneumococcal vaccine schedules (PVS) study: a cluster-randomised, non-inferiority trial of an alternative versus standard schedule for pneumococcal conjugate vaccination—statistical analysis plan (2022) (1)
RESEARCH ETHICAL COMMITTEES (1983) (1)
Analysis of partial and complete protection in malaria cohort studies (2013) (1)
ELIMINATION OF MALARIA – HALF-WAY THERE (2017) (1)
Pneumococcal conjugate vaccination schedules in infants—acquisition, immunogenicity, and pneumococcal conjugate and yellow fever vaccine co-administration study (2022) (1)
Serotype Profile of Nasopharyngeal Isolates of Streptococcus pneumoniae Obtained from Children in Burkina Faso before and after Mass Administration of Azithromycin (2020) (1)
World Health Organisation Technical Report Series No. 448: Factors Regulating the Immune Response (1971) (1)
AIDS in Africa. (1984) (1)
Correction: Modelling the Epidemiological Impact of Intermittent Preventive Treatment against Malaria in Infants (2009) (1)
Impact of mass administration of azithromycin as a preventive treatment on the prevalence and resistance of nasopharyngeal carriage of Staphylococcus aureus (2021) (1)
Editorial: Emerging and resurgent infections (1997) (1)
Aetiology of Lobar Pneumonia Determined by Multiplex Molecular Analyses of Lung and Pleural Aspirate Specimens in The Gambia (2021) (1)
PHARMACOKINETIC AND PHARMACODYNAMIC PROPERTIES OF DIHYDROARTEMISININ-PIPERAQUINE IN SEASONAL MALARIA CHEMOPREVENTION IN YOUNG CHILDREN (2018) (1)
Priorities in reducing child mortality: Azithromycin and other interventions (2020) (1)
Brexit and What It Means for Global Health (2018) (1)
Prevalence of malaria and helminth infections in rural communities in northern Sierra Leone, a baseline study to inform Ebola vaccine study protocols (2022) (1)
Malaria: the impact of treated bed nets on childhood mortality in the Gambia (1992) (1)
Effect of seasonal malaria chemoprevention plus azithromycin on Plasmodium falciparum transmission: gametocyte infectivity and mosquito fitness (2021) (1)
MICROBIAL-ANTIGEN DETECTION (1974) (1)
Letter: Bacteriological findings in pneumonia. (1974) (1)
Pilot study of the use of procalcitonin to predict bacterial pneumonia in the Gambia [Abstract] (2004) (0)
Principles of Medicine in Africa: Meningitis (2013) (0)
Practice point 56 – Managing an outbreak of meningococcal disease in an African village (2010) (0)
[From genomics to surveillance, prevention and control: new challenges for the African meningitis belt]. (2006) (0)
Malaria mortality and morbidity in Africa [editorial] (1999) (0)
Letter: Microbial-antigen detection. (1974) (0)
Follow-up of Gambian 9-valent pneumococcal conjugate vaccine trial participants who experienced acute lower respiratory infection aged less than 2.5 years (2010) (0)
(2018). Development of a PCR algorithm to detect and characterize Neisseria meningitidis carriage isolates in the African meningitis belt. (12), (2018) (0)
Arabic literacy: A reply (1988) (0)
Non-immune human sera at higher concentrations inhibit Plasmodium falciparum growth in vitro. (1988) (0)
A history of malaria (2008) (0)
Increased Concentrations ofInterleukin-6 andInterleukin-1 Receptor Antagonist andDecreased Concentrations ofBeta-2-Glycoprotein I inGambianChildren withCerebral Malaria (1994) (0)
Rapid Diagnostic Tests for Field Laboratories in Developing Countries (1991) (0)
Toward a Malaria Vaccine (2009) (0)
Data from a study of Guinea worm infection in northern Nigeria, 1971-1974 (2017) (0)
Tropical medicine. Not a white elephant. (1996) (0)
Jenner reborn: a new vaccine institute (2009) (0)
Assessment of malaria transmission from human to mosquitoes in seasonal malaria chemoprevention in the western region of Burkina Faso (2017) (0)
Gamougam, K., ... MenAfriCar Consortium (2018). Development of a PCR algorithm to detect and characterize Neisseria meningitidis carriage isolates in the African meningitis (2018) (0)
Parasite Immunology and the clinical immunologist (2001) (0)
A revival of the older methods of diagnosis and treatment of pyogenic meningitis. (1975) (0)
Dual sampling for STI research, prevention, and treatment (2012) (0)
Helicobacter pylori inGambian children with chronic diarrhoea andmalnutrition (1990) (0)
Meningococcal infection andproteolytic control (1978) (0)
Childhood meningitis in rural Gambia: 10 years of population-based surveillance (2022) (0)
Child Malnutrition at the Onset of Malaria Transmission: Impact on Subsequent Malaria Morbidity and Anti-Plasmodium Falciparum Antibody Response (2008) (0)
Patterns and seasonality of malaria transmission in a rural endemic area in middle Ghana (Kintampo district) (2005) (0)
Delivery of Intermittent Preventive Treatment of Malaria to Ghanaian Children: A Cost-Effectiveness Study (2007) (0)
Speaker and poster abstracts from the Second International Conference of the Journal of Travel Medicine and Infectious Disease: Speaker abstracts (2007) (0)
A randomized, double-blind, placebo-controlled trial of atovaquone-proguanil versus sulfadoxine-pyrimethamine in the treatment of Zambian children with severe Plasmodium falciparum malarial anaemia: Society Meeting at Manson House, London, 13 December 2001: Research in progress: short presentation [ (2002) (0)
Letter: Diagnosis of pyogenic meningitis. (1976) (0)
Comparative study ofgroupA andgroupC meningococcal infection (1977) (0)
DIAGNOSIS OF PYOGENIC MENINGITIS (1976) (0)
London School of Hygiene (0)
Spondyloarthritis in the Gambia - Evidence for a non-HLA B27 protective effect. (1996) (0)
Correction: Effect of Removing Direct Payment for Health Care on Utilisation and Health Outcomes in Ghanaian Children: A Randomised Controlled Trial (2009) (0)
AZ-SMC Trial - Weekly survey dataset (2020) (0)
An MHC Class II Allele is Associated with Clearance of Hepatitis B Virus Infection (1995) (0)
POLYARTHRITISIN WESTERN NIGERIA II. STILL'SDISEASE (1969) (0)
Book: Academics, Epidemics, Politics by Idris Mohammed (2011) (0)
Immunosuppression in Malaria and Trypanosomiasis (2008) (0)
Table I. Estimate of the mortality from malaria in African children Area No. of children Estimated malaria Number of 7 years old mortality/1000 children/ malaria deaths (millions) year (thousands) (1990) (0)
Research on Emerging Infections Offers an Opportunity for Public Health Intelligence on Non-Communicable Diseases: Hypertension Prevalence in Volunteers for an Ebola Vaccine Trial in Northern Sierra Leone (2020) (0)
HIGH EFFICIENCY OF VERTICAL TRANSMISSION OF HEPATITIS C VIRUS AMONG BABIES BORN TO HUMAN IMMUNODEFICIENCY VIRUS-NEGATIVE WOMEN (1995) (0)
Meningococcal carriage in Gambian children at the start of a meningococcal group A epidemic (1998) (0)
Not a white elephant (1996) (0)
Evaluation ofanalgorithm fortheintegrated managementofchildhood illness inanareawith seasonal malaria intheGambia (1997) (0)
IgM deficiency in Nigerians. (1977) (0)
Host-mediated selection impacts the diversity of Plasmodium falciparum antigens within infections (2018) (0)
ASSOCIATION OF Fc (cid:1) RECEPTOR IIa (CD32) POLYMORPHISM WITH SEVERE MALARIA IN WEST AFRICA (2003) (0)
Effect of 4 years of seasonal malaria chemoprevention on the acquisition of antibodies to Plasmodium falciparum antigens in Ouelessebougou, Mali (2021) (0)
Landes Highlights (2013) (0)
Diversity of Plasmodium falciparuin infections within a trial of intermittent preventive treatment in Ghanian children (2008) (0)
Need for Local Laboratory Reference Values in Recruitment into Studies of Emerging Infectious Diseases: Insight from Participant Screening for an Ebola Vaccine Trial in a Rural African Setting (2020) (0)
Intermittent Preventive Treatment of Malaria in Infants in an Area of High Sp Resistance in Tanzania: A Randomized Double Blind Placebo Controlled Trial of Sp, Lapdap or Mefloquine for Prevention of Malaria in Infants (2008) (0)
The prevalence of molecular markers of resistance to sulfadoxine-pyrimethamine among pregnant women at first antenatal clinic attendance and delivery in the forest-savannah area of Ghana (2022) (0)
AZ-SMC Trial - Drug administration dataset (2020) (0)
Oumar; Milligan, Paul; (2017) Safety and Efficacy of Adding a Single Low Dose of Primaquine to the Treatment of Adult Patients With Plasmodium falciparum Malaria in Senegal, to Reduce Gametocyte (2020) (0)
The Contribution of The Gambia to Malaria Research (2014) (0)
Morbidity and mortality at Malumfashi Nigeria 1974-79: studies of child health in Hausaland. (1991) (0)
Myasthenia gravis in Africans. (1967) (0)
Book Review Handbook of Meningococcal Disease: Infection Biology, Vaccination, Clinical Management Edited by Matthias Frosch and Martin C.J. Maiden. 544 pp., illustrated. Weinheim, Germany, Wiley-VCH, 2006. $240. 978-3-527-31260-3 (2007) (0)
Abrogation of post-my e l o a b l a t i v e c h e m o t h e r a py neutropenia by ex-v i v o expanded autologous CD34-positive cells (1999) (0)
Effect of Age and Vaccination With a Pneumococcal Conjugate Vaccine on the Density of Pneumococcal Nasopharyngeal (2012) (0)
Treponemal infection and outcome of pregnancy [reply] (1994) (0)
The Long Struggle Against Malaria in Tropical Africa by James L. A. Webb, Jr. (review) (2016) (0)
Hierarchical genomic analysis of carried and invasive serogroup A Neisseria meningitidis during the 2011 epidemic in Chad (2017) (0)
Determining malaria parasite density in thick blood films (1992) (0)
Seropositivity rates and GMTs/GMCs before (pre-challenge) and 1 month after (post-challenge) a polysaccharide challenge dose had been given (booster ATP cohort for immunogenicity) (2008) (0)
Immunological memory 5 years after meningococcal conjugate vaccination (1999) (0)
Policy Implications of the Results from the Randomized Double Blind Placebo Controlled Trial of Sp, Lapdap or Mefloquine for Prevention of Malaria in Infants Study in North-Eastern Tanzania (2008) (0)
Correction: Randomized Controlled Trial of RTS,S/AS02D and RTS,S/AS01E Malaria Candidate Vaccines Given According to Different Schedules in Ghanaian Children (2010) (0)
Controlling epidemic meningitis in Africa (2011) (0)
Emerging and resurgent infections. (1997) (0)
AZ-SMC Trial - School child parasitaemia dataset (2020) (0)
Pneumococcal Conjugate Vaccination Schedules Acquisition, Immunogenicity and Pneumococcal Conjugate and Yellow Fever Vaccine Co-Administration Study (2021) (0)
meningococci and pneumococci . fluid on the growth of Inhibitory effect of cerebrospinal (0)
Immunology of Malaria: World Health Organization, Technical Report Series No. 396 (1969) (0)
Ebola Virus Glycoprotein IgG Seroprevalence in Community Previously Affected by Ebola, Sierra Leone (2022) (0)
Immunoglobulin Levels in C.S.F (1970) (0)
Epidemiology of malaria among pregnant women during their first antenatal clinic visit in the middle belt of Ghana: a cross sectional study (2020) (0)
Prevalence of malaria-helminth co-infections among children living in a setting of high coverage of standard interventions for malaria and helminths: Two population-based studies in Senegal (2023) (0)
Immune response of a two-dose heterologous Ebola vaccine regimen: summary of three African clinical trials using a single validated Filovirus Animal Nonclinical Group enzyme-linked immunosorbent assay in a single accredited laboratory (2023) (0)
Seasonality in malaria transmission: implications for case-management with long-acting artemisinin combination therapy in sub-Saharan Africa (2015) (0)
Nutritional status in young children prior to the malaria transmission season in Burkina Faso and Mali, and its impact on the incidence of clinical malaria (2021) (0)
Epidemiology of subpatent Plasmodium falciparum infection: implications for detection of hotspots with imperfect diagnostics (2013) (0)
Ensuring access to MMV's medicines (2011) (0)
Impact of seasonal RTS,S/AS01E vaccination plus seasonal malaria chemoprevention on the nutritional status of children in Burkina Faso and Mali (2022) (0)
Lobar Pneumonia Pulmonary Tuberculosis Controls Number Percentage Number Percentage Number Percentage Tested Positive Tested Positive Tested Positive Gram stain Predominant diplococci (0)
Cost effectiveness of intermittent screening followed by treatment versus intermittent preventive treatment during pregnancy in West Africa: analysis and modelling of results from a non-inferiority trial (2016) (0)
Effect of 4 years of seasonal malaria chemoprevention on the acquisition of antibodies to Plasmodium falciparum antigens in Ouelessebougou, Mali (2021) (0)
Seasonal vaccination against malaria: a potential use for an imperfect malaria vaccine (2017) (0)
Data repository for AZ-SMC - a trial of seasonal malaria chemoprevention combined with azithromycin in African children (2020) (0)
Aetiology of lobar pneumonia determined by multiplex molecular analyses of lung and pleural aspirate specimens in the Gambia: findings from population-based pneumonia surveillance (2022) (0)
The risk of malaria in Ghanaian infants born to women managed in pregnancy with intermittent screening and treatment for malaria or intermittent preventive treatment with sulfadoxine/pyrimethamine (2016) (0)
Effects of proactive vs fixed community health care delivery on child health and access to care: a cluster randomised trial secondary endpoint analysis (2023) (0)
Combining malaria vaccination with chemoprevention: a promising new approach to malaria control (2021) (0)
Pneumonia, Meningitis, and Septicemia in Adults and Older Children in Rural Gambia: 8 Years of Population-Based Surveillance (2022) (0)
Optimal dosing of dihydroartemisinin-piperaquine for seasonal malaria chemoprevention in young children (2019) (0)
Distance mediates the effect of removing financial barriers to accessing care: results of a randomized controlled trial in Ghana (2009) (0)
NmCV-5 meningococcal vaccine: Neisseria meningitidis' nemesis? (2018) (0)
COVID-19 Vaccine Acceptability Among Healthcare Facility Workers in Sierra Leone, the Democratic Republic of Congo and Uganda: A Multi-Centre Cross-Sectional Survey (2022) (0)
Pneumococcal vaccination for acute otitis media. Commentary (2006) (0)
AZ-SMC Trial - Cross-sectional dataset (2020) (0)
Factors affecting poor measles vaccination coverage in sub-Saharan Africa with a special focus on Nigeria: a narrative review. (2022) (0)
Safety and effectiveness of delivering mass drug administration for helminths through the seasonal malaria chemoprevention platform among Senegalese children: study protocol for a randomised controlled trial (2022) (0)
The duration of protection against clinical malaria provided by the combination of seasonal RTS,S/AS01E vaccination and seasonal malaria chemoprevention versus either intervention given alone (2022) (0)
Using molecular markers of Plasmodium falciparum drug resistance to evaluate the use of intermittent preventive treatment of children in Senegal (2003) (0)
Rheumatoid factor, immunoglobulin levels and parasitic infections in three West African population samples (1974) (0)
Hot spot or not: a comparison of spatial statistical methods to predict prospective malaria infections (2014) (0)
Estimating the burden of malaria and soil-transmitted helminth co-infection in sub-Saharan Africa: a geospatial study (2022) (0)
Serology describes a profile of declining malaria transmission in Farafenni, The Gambia (2015) (0)
Asymptomatic Malaria Infection and the Immune Response to the 2-Dose Ad26.ZEBOV, MVA-BN-Filo Ebola Vaccine Regimen in Adults and Children (2022) (0)
Nelson's personal experiences of surgery (2005) (0)
Efficacy of two artemisinin-based combinations for the treatment of malaria in pregnancy in India: a randomized controlled trial (2018) (0)
Abstract 2757: Using liquid biopsies and NGS as tools to analyze mutation burden and copy number variation in the blood of a patient with triple negative breast cancer to better inform therapeutic targets (2017) (0)
Impact of seasonal RTS,S/AS01E vaccination plus seasonal malaria chemoprevention on the nutritional status of children in Burkina Faso and Mali (2022) (0)
Correction to: Partnership for Research on Ebola VACcination (PREVAC): protocol of a randomized, double-blind, placebo-controlled phase 2 clinical trial evaluating three vaccine strategies against Ebola in healthy volunteers in four West African countries (2021) (0)
Malaria in Pregnancy in West Africa: Evidence for Carriage of Infections Acquired Before Pregnancy (2019) (0)
Trends in multiplicity of Plasmodium falciparum infections among asymptomatic residents in the middle belt of Ghana (2013) (0)
Prevalence of immunoglobulin G and M to SARS-CoV-2 and other human coronaviruses in The Democratic Republic of Congo, Sierra Leone, and Uganda: A longitudinal study (2023) (0)
RTS,S/AS01 Malaria Vaccine in African Children REPLY (2012) (0)
Challenges and lessons learned during the planning and early implementation of the RTS,S/AS01E malaria vaccine in three regions of Ghana: a qualitative study (2022) (0)
Recombination and selection in polymorphic Plasmodium falciparum antigen genes in natural populations (1998) (0)
Longitudinal estimation of Plasmodium falciparum prevalence in relation to malaria prevention measures in six sub-Saharan African countries (2017) (0)
Resurgent and delayed malaria (2022) (0)
Nationwide survey ofbednet useinrural Gambia (1994) (0)
Delivery strategies for malaria vaccination in areas with seasonal malaria transmission. (2023) (0)
transmission area in Ghana: a prospective cohort study (2013) (0)
Primaquine and Plasmodium vivax Malaria Recurrence in Brazil. (2022) (0)
Effect of seasonal malaria chemoprevention plus azithromycin on Plasmodium falciparum transmission: gametocyte infectivity and mosquito fitness (2021) (0)
Caregivers’ perception of risk for malaria, helminth infection and malaria-helminth co-infection among children living in urban and rural settings of Senegal: A qualitative study (2022) (0)
Piloting a pragmatic clinical audit tool for quality improvement in rural paediatric care in northern Sierra Leone (2023) (0)

This paper list is powered by the following services:

Other Resources About Brian Greenwood

en.wikipedia.org

What Schools Are Affiliated With Brian Greenwood?

Brian Greenwood is affiliated with the following schools: